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Abstract
The diplomonad protist, Giardia lamblia, colonizes and replicates in the small intestine of
mammals. In humans, Giardia infection (known as giardiasis) can be symptomatic or asymptomatic
with the former being associated with fatty stool, abdominal pain, malnutrition, and weight loss. Both
cell-mediated and humoral immune responses against Giardia infection are possible, and adaptive
responses have been reported to be important for controlling the infection. Non-immune components
such as secretory immunoglobulin, intestinal lipids, and bile acids also play significant roles in
determining the severity of the infection by Giardia.
Giardia exists in two morphologic forms—trophozoites and cysts—and maintains a simple life
cycle. Exposure of cysts to gastric acid during passage through the human stomach triggers excystation
(morphological changes from cyst to trophozoites), while factors in the small intestine, where
trophozoites colonize, induce encystation or cyst formation. The disease is transmitted by water-resistant
cysts, which are excreted in the feces of humans and pass on to a new host via contaminated food and
water. The production of viable giardial cysts is critical for successful transmission and spreading of the
disease.
Our laboratory is interested in investigating the lipid metabolism in Giardia because this parasite
is unable to synthesize the majority of its own lipids de novo and depends on exogenous lipids for its
growth and encystation. In this regard, I am interested in identifying the role of sphingolipids (SLs)
during cyst formation. We have shown earlier that, unlike higher eukaryotes Giardia expresses fewer SL
genes, which are differentially regulated during encystation. This suggests that there could be a link
between SL synthesis and giardial encystation. Furthermore, D-threo-1-phenyl-2-palmitoylamino-3morpholino-1-propanol (PPMP), an inhibitor of glucosylceramide (GlcCer) synthesis, blocks replication
of trophozoites, induces karyokinesis, and inhibits cyst production by Giardia, which indicates that
GlcCer plays an essential role in the life cycle of this waterborne pathogen.
The goal of my dissertation is to provide understanding of the overall process of cyst production
and how the enzyme of GlcCer synthesis (i.e., GlcT1) modulates this process. I have used various
molecular and biochemical methodologies to address this question with the help of two separate but
vi

interrelated Specific Aims. In Specific Aim 1, I asked if giardial glucosylceramide transferase enzyme
(gGlcT1) regulates encystation and cyst production by Giardia, and the goal of Specific Aim 2 was to
investigate whether glucosylceramide transferase regulates ESV (encystation-specific vesicle)
biogenesis and cyst viability by maintaining the cellular lipid homeostasis.
Briefly, I found that overexpression of gGlcT1 enzyme generated aggregated/enlarged ESVs and
congregated cysts with reduced viability. The knocking down of gGlcT1 activity blocked ESV
biogenesis completely and produced mostly non-viable cysts. However, when gGlcT1-overexpressed
Giardia was knocked down with anti-gGlcT1 morpholino oligonucleotide (i.e., GlcT1 rescued parasites)
the enzyme activity, ESV biogenesis, and cyst viability returned to normal, suggesting that the regulated
expression of gGlcT1 is important for encystation and viable cyst production. Overexpression of gGlcT1
increased the influx of membrane lipids and fatty acids without altering the fluidity of plasma
membranes, which indicates that the expression of gGlcT1 is linked to lipid internalization and
maintenance of the overall lipid homeostasis in this unicellular organism. Based on these results, I
propose that gGlcT1 is a key player in ESV biogenesis and Giardia cyst viability and that it could
therefore be exploited for developing new anti-giardial drugs or a vaccine to control giardiasis.
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Chapter 1: Introduction
Giardia lamblia is an intestinal protozoan that causes giardiasis, a waterborne illness throughout
the world including the U.S. The symptoms of giardiasis are diarrhea, fatigue, vomiting, weight loss and
malabsorption. Diarrhea is considered the second major cause of death of children in developing
countries (WHO Report, 2013). Parasitic protozoans make up a significant portion of cases of diarrhea
and Giardia has contributed to 35.2% of all protozoan outbreaks from 2004-2010 (Lane et al. 2002;
Baldursson et al. 2011). According to the Central for Disease Control and Prevention (CDC) report,
there were 19000 cases of giardiasis between 2010-2012 in the U.S. [CDC report (2012) and (Yoder et
al. 2010)]. Giardia has eight different assemblages (A-H) and human infections being consolidated
within assemblage A and B (Kulda J 1978; Mayrhofer et al. 1995; Lasek-Nesselquist et al. 2010). Also,
there have been cases of cross-infections between species such as the one between humans and dogs.
Dogs are infected by assemblages C and D however, one dog was recorded to have both B and C
infections (Hopkins et al. 1997). Moreover, small portions dairy cattle have been shown to be infected
with assemblage A (<20%) in Canada and Australia (O'Handley et al. 2000; Applebee 2002). Besides
dogs and cattle, many animals can serve as reservoirs for humans.
Giardiasis can be symptomatic and non-symptomatic. Sixty percent of all infections worldwide
are asymptomatic where children are mostly affected (Ortega et al. 1997; ECDPC/ECDC, 2008). Severe
and chronic giardiasis have been shown to cause irritable bowel syndrome, fatigue and in rare cases
arthritis, cholecystitis, and pancreatitis even after the infection has cleared (Wolfe 1992). In children,
chronic giardial infection has been shown to cause urticaria, low IQ and stunted growth (Sackey et al.
2003; Wright 2012). Incidentally, no pathogenic marker has been identified in Giardia and no suitable
animal model to study giardiasis was developed.
Giardia has two morphologic forms: The metabolically active and vibrant trophozoites, and a
relatively dormant cyst (Fig 1). The infective cyst is transmitted through fecal contaminated water or
food, and it is estimated that 10 cysts or less are needed to establish an infection (Talal et al. 1994).
When cysts are ingested, the cyst-wall lining is degraded by the low pH environment of the stomach to
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Figure 1: Morphology of Giardia
The giardial trophoizoite (active stage) and the cyst (dormant stage). The active trophozoite stage
contains two nuclei (n) with a set of basal bodies (bb) between them. For movement the parasite relies
on anterior (af), caudal (cf) and posterior flagella (pf). The dormant cyst contains four nuclei (n)
enclosed within a cyst wall (cw).
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begin excystation. Upon its release into the duodenum, Giardia cyst differentiates into two trophozoites
and begins colonizing the small intestinal lumen where it remains non-invasive and multiplies by
asexual reproduction (binary fission). Further down in the small intestine, Giardia undergoes
encystation or cyst formation (Adam 2001).
Giardia is a binucleate unicellular parasite that is able to survive outside in the environment by
forming a cyst. Designated as an early-divergent eukaryote, Giardia maintains a unique system which is
comprised of both eukaryotic and prokaryotic characteristics (Morrison et al. 2007). It has no classical
Golgi apparatus, but secretes Golgi-like vesicles called Encystation-Specific Vesicles (ESVs) during the
cyst formation (Reiner et al. 1990; Stefanic et al. 2009). Although Giardia lacks mitochondrion, it
synthesizes an incomplete version of mitochondrion called a “mitosome” (Regoes et al. 2005).
Interestingly, this “mitosome” is not known to carry out any of the mitochondrial functions and the
significance of this incomplete/non-functional organism is not clear at this point. Instead of lysosomes,
this parasite contains peripheral vacuoles (PV) that act as an endosome-lysosome fusion vesicle and
store cathepsin B-like protease enzyme (Ward et al. 1997). These PVs fuse with the cell membrane to
allow extracellular materials to be endocytosed (Touz et al. 2003). The cyst contains four nuclei of
which two trophozoites will emerge during excystation. However, during encystation or differentiation
into cyst stage (discussed below), Giardia exhibits polyploidy and replicates its genome from 4N  8N
 16N (Poxleitner et al. 2008; Reiner et al. 2008; Carpenter et al. 2012).

1.1 GIARDIA: MOLECULAR MECHANISMS OF ENCYSTATION AND EXCYSTATION

While the exact mechanism that trigger encystation and excystation are not well understood, it has been
proposed that exposing cells to conditions that most closely resemble those within the host are most
effective in producing trophozoites and cysts (Bingham et al. 1979). In the host, cysts are exposed to
highly acidic conditions as they pass through the stomach, followed by a quick neutralization once in the
duodenum. In the small intestine, trophozoites are exposed to bile salts and digestive enzymes with
detergent-like activity. In the jejunum, excystation takes place and Giardia comes in contact with lactic
3

acid produced by bacteria present in the small intestine (Fig 2). Furthermore, it has been shown that
exposure to low pH and pancreatic proteases is crucial for the excystation process (Boucher et al. 1990).
An excyzoite (i. e, a cyst in the process of excystation) divides twice to produce four trophozoites
(Bernander et al. 2001).
When encystation is initiated in Giardia, the flagella are internalized and the ventral disk is
deconstructed, resulting in the parasite detaching from the small intestinal lumen (Lauwaet et al. 2007).
Cyst Wall Proteins (CWPs) 1, 2 and 3 begin to be synthesized for transport toward the plasma
membranes of trophozoites. The production of CWPs have been shown to be regulated by sterol
regulatory-element-binding proteins (SREBPs), in which many proteins can be post-translationally
modified by the intermediates of cholesterol metabolism (Lujan et al. 1995; Worgall et al. 2004).The
CWPs are transported by the ESVs (Fig 3), ultimately fusing with PVs before laying down the cyst wall
(Lauwaet et al. 2007). Giardial cyst wall is comprised of 40% protein including high-cysteine nonvariant cyst protein (HCNCp), giardial Myb2, cysteine-protease-2, novel cyst proteins with epidermal
growth factor repeats and Rab 11 (DuBois et al. 2008; Huang et al. 2008; Castillo-Romero et al. 2010).
The remainder of the cyst wall is composed of lipids and carbohydrates. N-acetylgalactosamine
(GalNAc) is the main carbohydrate found in the cyst wall and with all of these components, Giardia is
able to withstand the oxidative environment in the cyst form (Gerwig et al. 2002). Cumulative reports
suggest that Giardia has evolved a well-regulated secretory pathway to transport organelles and vesicles
during encystation and excystation (Faso et al. 2011). During encystation, in the small intestine,
trophozoites synthesize ESVs that are necessary to transport CWPs and other cyst-wall materials to the
plasma membrane to form the cyst wall. The biogenesis of ESVs take place in the endoplasmic
reticulum (ER), located in the perinuclear membranes in early-encystation cells, and then distributed
extensively in the periphery of the cell (in close proximity to peripheral vacuoles) in late encystation
phase (McCaffery et al. 1994). Presumably, the first half of the encystation phase is involved in
triggering the encystation-specific genes, proteins and enzymes that are packaged into newly
synthesized ESVs. Although, Giardia has no Golgi, it appears that ER participates in Golgi-like sorting
and ESV itself shows Golgi-like appearance (Reiner et al. 1990; Stefanic et al. 2009). Thus like a
4

Figure 2: Lifecycle of Giardia lamblia
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Figure 3: Formation of ESVs during encystation
Lower magnification (A) and higher magnification (B) TEM sections stained with “tannic acid”
showing ESVs (arrow) during encystation. The ESVs head toward the plasma membrane (arrowhead).
Nuclei (N) and median body (MB) are present. The confocal image (C) was treated with giardial cyst
antibody to mark the ESVs (arrow) during encystation.
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Golgi apparatus, ESVs contain Golgi-like cisternae that are involved in transporting cyst-wall
components to plasma membranes (Faso et al. 2011). This postulation can be further supported by the
fact that the ESV formation and secretion process in encysting Giardia is dependent upon COPII and
small GTPase Rab 1, both markers for Golgi activity (Stefanic et al. 2009). Excystation, unlike
encystation is somewhat simpler. During the passing of cysts through an acidic environment in the
stomach, a cathepsin-B like protease (CP2) secreted from PVs degrades CWPs and at the same time
parasite-specific glycohydrolase cleaves GalNAc fibrils of the cyst wall (Chatterjee et al. 2010).
Secretion of CP2 into the inter-cyst wall space is triggered during excystation. Furthermore, the
dephosphorylation of cyst wall proteins by secreted lysosomal acid phosphatases is critical to trigger
excystation by Giardia (Slavin et al. 2002).

1.2 GIARDIA-LIPID INTERACTIONS IN THE HUMAN SMALL INTESTINE

Metabolism in Giardia is mainly processed through carbohydrate-derived energy. The
conversion of glucose to pyruvate occurs through Embden-Meyerhof-Parnas and hexose monophosphate
shunt pathways and unlike higher eukaryotes, it is not compartmentalized (Lindmark 1980; Adam
2001). Another metabolic pathway in this parasite is the metabolism of alanine, aspartate, and arginine
amino acids (Mendis et al. 1992; Schofield et al. 1992; Schofield et al. 1995). Giardia as a
microaerophile, produces ATP by converting arginine to orthinine (substrate level phosphorylation)
without the presence of oxygen. Moreover, arginine can be catabolized to citrulline by arginine
deaminase, which yields 7-8 more ATPs more than glucose (Schofield et al. 1992). Other than glucose
and arginine, intestinal lipids also play an important role in giardial biology. During their colonization in
the human small intestine, Giardia is exposed to bile salts and dietary fats. Reports suggest that
intestinal fatty acids kill Giardia, whereas mucus and bile salts protect the parasite from being killed by
fatty acids and other small intestinal factors (Reiner et al. 1986; Das et al. 1988). Bile acids were also
proposed to facilitate the transport of intestinal lipids into Giardia by forming mixed micelles (Das et al.
1997). Free fatty acids generated from phospholipids and triglycerides are inhibitory to the growth of
Giardia (Reiner et al. 1986; Das et al. 1988). Studies suggest that dodecanoic (C12:0) acid (also known as
7

lauric acid) possesses an anti-giardial property at a reasonably low concentration (Rayan et al. 2005).
This medium-chain fatty acid accumulates inside trophozoites and alters membrane permeability and
integrity. Giardia has the machinery to neutralize the toxic effects of free fatty acids by forming
complex with membrane proteins, lipids, and carbohydrates (Das et al. 1991; Gibson et al. 1999; Touz et
al. 2005). However, Gillin et al. (1987; 1988) have demonstrated that at lower concentrations, fatty acids
induce encystation. Subsequently, cholesterol and bovine bile, which Giardia obtains from the growth
medium, were shown to induce encystation (Kane et al. 1991; Lujan et al. 1996). Interestingly, the
homologues of sterol regulatory-element-binding proteins (SREBPs) were identified in Giardia and
found to regulate the expression of CWP genes during encystation (Worgall et al. 2004). Several
proteins of the parasite can undergo post-translational modification by the intermediate of cholesterol
(isoprenyl-group) biosynthetic pathway (Lujan et al. 1995) and it is possible that these modifications of
giardial proteins are important for maintaining membrane integrity and functions.

1.3 AN ORGANISM WITH MINIMAL LIPID SYNTHESIS ABILITY
Since Giardia has a limited capability to synthesize lipid molecules de novo and as mentioned
above, the majority of lipids are obtained from the small intestinal environment and remodeled
accordingly (Das et al. 2001). Using radioactive acetate, glucose, glycerol, threonine, cholesterol and
glycerol-3-phosphate, Jarroll and his colleagues (1981) monitored the metabolic conversions of these
lipids into other lipid products. Surprisingly, it was noted that none of these radioactive precursors were
incorporated into other lipids. This proposal was further supported by Kaneda and Goutsu (1988) and
Mohareb et al. (1991), who showed that the lipid composition in Giardia is similar to that of the growth
medium.

Results

suggested

that

phosphatidylcholine

(PC),

phosphatidylethanolamine

(PE),

sphingomyelin (SM), and phosphatidylglycerol (PG) are present in both trophozoites and encysting
cells and do not change during encystation (Ellis et al. 1996). Our mass spectrometric results indicated
that PCs and PGs are the major phospholipids in Giardia. Seventeen different species of PGs are present
with various combinations of odd- and even-numbered, carbon-containing fatty acids. Relative
quantitation of individual lipids further elucidated that two PG species containing C18:1/C16:0 and
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C18:1/C16:0 were most abundant, followed by C16:0/C16:0 and/or C18:0/C14:0. Nineteen species of PCs were
detected and among them C18:1/C18:1 was found to be the major PC. In addition to PGs and PCs, six
species of PEs, three species of SMs and two species of phosphatidylinositols (PIs) were also detected
(Yichoy et al. 2009). Interestingly, except for lyso-PCs and PCs, no other phospholipids are present in
bile and serum, suggesting that many of these phospholipids (specifically PG and PE) in Giardia could
be synthesized de novo via CDP-DAG and/or fatty acid and head-group remodelling pathways (Das et
al. 2001). This hypothesis can be further supported by the fact that radiolabeled fatty acids are directly
incorporated into giardial phospholipids (Blair et al. 1987; Stevens et al. 1997; Gibson et al. 1999;
Subramanian et al. 2000; Vargas-Villarreal et al. 2007), indicating that Giardia has the enzymes and
pathways to synthesize new phospholipids most likely by fatty acid remodelling reaction which is also
known as the Lands cycle (Das et al. 2001). Radiolabeled bases (i.e., choline, inositol, ethanolamine,
serine and glycerol) are also incorporated into respective phospholipids of trophozoites when added to
the culture medium (Subramanian et al. 2000); Das et al. unpublished), suggesting that like fatty acid
remodelling reactions, base exchange or headgroup-exchange reactions are operative in this parasite
suggesting that Giardia relies more on remodelling pathways rather than the de novo synthesis via CDPdiacylglycerol pathway.

1.4 STORIES TOLD BY THE LIPID GENES
The curiosity that Giardia has a limited lipid synthesis ability prompted us to analyze the lipid
and fatty acid genes that are annotated in the Giardia Genome Database (www.GiardiaDB.Org;
(Morrison et al. 2007). Nine genes of phospholipid synthesis, transport and metabolism were identified
in Giardia, including the putative homologues of PC synthase (gPCS), phosphatidylinositol synthase
(gPIS), PI transfer protein (alpha isoforms, gPITPα), phosphatidylglycerolphosphate synthase (gPGPS),
phospholipid-transport (gPLT) ATPase 1A and

IIB, phosphatidylserine

synthase (gPSS),

phosphatidylserine decarboxylase (gPSD) and headgroup (choline/ethanolamine) kinases. The presence
of phospholipid-transport ATPase IA and IIB (also known as phospholipid flippases or gFLIP) suggest
that Giardia has evolved an efficient mechanism to internalize phospholipid molecules, especially PC
9

from its small intestinal environment. Among various phospholipid genes, the presence of gPIS, gPGPS,
gPSS and gPSD are also interesting and may signify the capability of Giardia to synthesize limited
phospholipids de novo. Earlier, we have demonstrated that genes for gPGPS and gPSD are expressed in
Giardia and remain unchanged throughout the life-cycle of the parasite, suggesting that they may
function as a house-keeping gene (Yichoy et al. 2009).
The Giardia genome project predicts the presence of nine fatty-acid (FA) transport, synthesis,
and metabolic genes. Three 1-acyl-sn-glycerol-3-phosphate acyltransferases (SLCs)—i.e., gSLC2,
gSLC3 and gSLC4 —were annotated in the database, suggesting that Giardia might use these gene
products to import fatty acids from its environment. Other FA genes annotated are putative
lysophosphatidic acid acyltransferase (gLAAT), elongase 1 (gELO) several long-chain fatty-acid
(LCFA)-CoA ligases (gLCFA-CoA ligases) [i.e., LCFA-CoA ligase 4 (gLCFLA4) and three different
forms of LCFA-CoA ligase 5 (gLCFLA5)] and acetyl-CoA/pyruvate carboxylase (gACPC). The
presence of these FA genes further indicates that very basic and essential FA metabolism can be carried
out by Giardia, such as transferring fatty acids across the membranes, forming reactive FA species (fatty
acyl-CoA), acylating lysophosphatidic acid (LPA) to form phosphatidic acid (PA), and elongating and
ligating FA chains (Table 2). Giardia contains two isoforms of secreted and cytoplasmic phospholipase
B enzymes (gplb) that are responsible for removing Sn1 and Sn2 fatty acids from a phospholipid at the
same time (Morgan et al. 2004).
Only five SL metabolic genes were annotated in the Giardia database, including the genes that
encode SPT 1 & 2, GlcT-1 (gglct1), and two separate ASMases enzymes (ASMase B [gasmase b] and
ASMase 3b [gasmase 3b]). It has been reported earlier that all of these five genes are expressed and
regulated differentially in two different stages of the life cycle of Giardia, suggesting that SL pathways
could be involved in modulating the growth and differentiation of this waterborne pathogen (Hernandez
et al. 2008). Various lipid kinase genes were also annotated. These include the genes for putative target
of rapamycin (gTOR), PI-3, -4, -5-trisphosphate 3-phosphatase (gPIPase), inositol-1, -4, -5trisphosphate 5-phosphatase (gITPase), inositol 5-phosphatase PI-3-kinase class 3 (gPIK), alpha
polypeptide of PI-3-kinase catalytic subunit (gPI3K), three isoforms of PI-4-phosphate 5-kinase
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(gPIPase), PI-4-kinase (gPI4K), and PI-glycan biosynthesis, class O protein (gPIG). The molecular and
bioinformatic analyses revealed that giardial TOR is an analogue of the FRAP/TOR of eukaryotes
expressed in dividing parasites and may not be inhibited by rapamycin (Morrison et al. 2002). The
bioinformatic analyses of three giardial PIKs genes (gPIKs)—two gIPKs (gPI3K-1 and gPI3K-2) and
one gPI4K—were also studied (Cox et al. 2006; Hernandez et al. 2007). The identified genes contain
catalytic (p110) but not regulatory (p85) subunits. Transcriptional analyses demonstrated that gpiks are
expressed in Giardia and modulated during encystation. In addition, two PI3K inhibitors, wortmannin
and LY 294002, inhibited the replication of trophozoites in culture, supporting the notion that PIKs’
activities could be linked to the growth and encystation of Giardia.

1.5 SPHINGOLIPIDS AND

ENCYSTATION

Sphingolipids (SLs) are sphingosine-based phospholipids that control various biological
mechanisms such as membrane biosynthesis, cell to cell communication, signal transduction and
apoptosis (Hanada 2005). Our lab has extensively studied the SL pathway in Giardia and found that this
parasite has a limited SL synthesis capability. As mentioned above, only five SL genes are present in
Giardia and they are: serine palmitoyltransferase-1 (gspt-1), serine palmitoyltransferase (gspt-2),
ceramide-glucosyltranferase-1 (gglct-1), sphingomyelinase b (smase b), and sphingomyelinase 3b
(smase 3b). It is clear that there are gaps within the SL pathway in this parasite, yet each portion of the
pathway seems to have a different role in its lifecycle. All five genes are differentially regulated during
encystation and giardial serine palmitoyltransferase enzyme (gSPT) is responsible for endocytosis. On
the other hand, giardial glucosyltransferase enzyme (gGlcT1) has been shown to partake in encystation,
whereas the function of another abundant SL-hydrolyzing enzyme, sphingomyelinase (gSMase) is still
not clear (Hernandez et al. 2008).
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1.6 THE KNOWLEDGE GAP AND THE FOCUS OF THE CURRENT DISSERTATION
Giardia is a non-invasive parasite, and the mechanism by which it causes disease is not clear. No
known toxin or virulence factor is secreted by this parasite but the ability of Giardia to form cysts could
be considered its “virulence determinant” because the formation of viable cysts allows this organism to
survive in a harsh environment and to spread the infection. The first step of cyst formation is the
synthesis of encystation-specific vesicles (ESVs) involved in transporting cyst-wall materials that later
fuse with the plasma membrane and lay down the cyst-wall. Three encystation-specific cyst-wall
proteins (CWP-1, -2, and -3) are expressed at the time of encystation and concentrated within the ESVs
(Lauwaet et al. 2007). Biochemical analyses demonstrate that cyst-wall of Giardia contains insoluble
filamentous materials that consist of glycoprotein and amino-sugar containing polysaccharides (Gerwig
et al. 2002; Sener et al. 2004) Despite all this information, the mechanism of encystation and cyst
formation is not well understood. Earlier experiments conducted in our laboratory indicated that SLs are
important for giardial encystation. L-cycloserine, an inhibitor of SPT was shown to block endocytosis
and endoplasmic reticulum/perinuclear targeting of Bodipy-conjugated ceramide in trophozoites which
could be reversed by 3-ketosphinganine, a product of this enzyme. Likewise, D-threo-1-phenyl-2palmitoylamino-3-morpholino-1-propanol (PPMP), an inhibitor of glycosylceramide (GlcCer) synthesis,
blocked karyokinesis and reduced the cyst production in culture (Hernandez et al. 2008). It has also been
reported that PPMP inhibits trophozoite replication and produces incompletely divided cells (doublets or
triplets) and thereby block encystation (Sonda et al. 2008; Stefanic et al. 2010). However, none of these
reports shed any light on the mechanism by which SLs, especially the enzyme, gGlcT1 regulates
encystation and cyst production by this parasite.
My dissertation focuses on understanding the unique and precise function of gGlcT1 and its role
in encystation and cyst formation. I found that modulation of gGlcT1 activity by overexpression and
knockdown affects the ESV biogenesis and cyst viability of Giardia. I also show that gGlcT1
overexpression disturbs lipid homeostasis in this parasite by elevating the intracellular levels of lipids,
cholesterol, and fatty acids without affecting the membrane fluidity. Finally, a model depicting the
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current results outline how the gGlcT1 enzyme may function during encystation. With this information
gGlcT1 can be targeted for developing new anti-giardial therapy.
.
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Chapter 2: Glucosylceramide Transferase Regulates Encystation and Cyst
Production by Giardia lamblia
The synthesis of glucosylceramide (GlcCer; a glycosphingolipid) is catalyzed by the
glucosylceramide transferase-1 (GlcT-1) enzyme that transfers glucose from UDP-glucose to ceramides
as shown below.
GlcT1
UDP-Glucose + Ceramide ------------------------- Glucosylceramide + UDP
Interestingly, ceramide, like many other lipids, is not synthesized de novo by this parasite. Our
laboratory has reported earlier that ceramide (an important lipid of plasma and endomembranes) is taken
up by Giardia from the cell exterior via the clathrin-dependent pathway and targeted to the endoplasmic
reticulum (ER)/perinuclear membranes (Hernandez et al. 2007). Studies also suggest that the GlcT1
enzyme in Giardia is embedded in the ER membranes where GlcCer synthesis apparently takes place
(Hernandez et al. 2008). Newly synthesized GlcCer then participates in encystation and cyst production
(Hernandez et al. 2008; Sonda et al. 2008; Stefanic et al. 2010). The conclusion—i.e., that GlcCer is
important for encystation stemmed from two different observations: (1) that the transcript of the gglct1
gene is upregulated during encystation, and (2) that D-threo-1-phenyl-2-decanoylamino-3-morpholino1-propanol (PPMP), an inhibitor of GlcCer synthesis, blocks encystation and cyst production by Giardia
in culture. However, what is not known is whether the gglct1 gene encodes the active gGlcT1enzyme,
and whether PPMP blocks encystation by inhibiting gGlcT1. The BLAST analysis reveals that the
gGlcT-1 sequence is highly divergent from other organisms, with Arabidopsis thaliana being the closest
relative with 32% amino acid identity. In addition, the catalytic domain gGlcT1 has yet to be elucidated.
Further study of gGlcT1 may help us in discovering the structural components and catalytic site of this
enzyme. The lack of similarity of gGlcT1 to other organisms may also help in finding a unique drug
target against this parasite.
In other organisms, GlcT1 has been implicated in several functions. The overexpression of
GlcT1 (also known as glucosylceramide synthase or GS) causes multi-drug resistance in breast cancer
cells and through the use of RNAi methodology this drug-resistant effect could be reversed (Sun et al.
2006). In diet-induced obesity in mice, the inhibition of GlcT1 decreased insulin resistance, whereas the
GlcCer synthase inhibitor Genz-123346 reversed cystogenesis in mice with autosomal polycystic kidney
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disease (Natoli et al. 2010; Yew et al. 2010). In terms of cell structure of Cryptococcus neoformans,
GlcCer is essential for cell-wall formation, cell growth, and budding, and Candida albicans and Pichia
pastoris with a GlcT1 deletion are resistant to RsAFP2, an antifungal plant defensin (Thevissen et al.
2004). In addition, in A. thaliana the inhibition of GlcCer synthase with PPMP disrupts Golgi
morphology and protein secretion (Melser et al. 2010).
The experiments described in Chapter 2 were carried out to identify the mechanism by which
GlcT1 regulates encystation and cyst production. It was mentioned in Chapter 1 (Introduction) that
during encystation ESVs are packed with CWPs that are synthesized in the ER. The ESVs are formed
directly from the ER, which in the case of Giardia is found throughout the cytoplasm, occasionally
connecting the plasma membranes to the PVs (Faso et al. 2011). I have used molecular methodologies
(i.e., overexpression, knockdown, and rescue) to modulate gGlcT1 activity and have evaluated the
biogenesis of ESVs and cyst production by this waterborne pathogen. I have also investigated whether
gGlcT1 activity is critical for maintaining the cyst viability because infections (giardiasis) are caused
when viable cysts are ingested by humans.

2.1 MATERIALS AND METHODS
2.1.1

Materials
Unless otherwise specified, all chemicals were purchased from Sigma-Aldrich Chemical Co. (St.

Louis, MO) and were of the highest available purity. Tetramethyl rhodamine (TMR)-conjugated goat
anti-mouse antibodies; fluorescent (NBD-conjugated) lipids; 4' and 6-diamidino-2-phenylindole (DAPI)
were purchased from Invitrogen (Carlsbad, CA). D-threo-1-phenyl-2-palmitoylamino-3-morpholino-1propanol (PPMP), and other lipid standards including [13C]-deuterated GM3 were purchased from
Matreya LLC (Pleasant Gap, PA). Glucosylceramide and lactosylceramide standards were obtained
from Avanti Polar Lipids (Albester, AL). Anti-giardial cyst and anti-AU1 antibodies (monoclonal) were
obtained from Santa Cruz Biotechnology (Santa Cruz, CA) and Covance Laboratory (San Diego, CA),
respectively. UDP-[14C] glucose (300 mCi/mmol) was purchased from American Radiolabeled
Chemical (St. Louis, MO).
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2.1.2

Trophozoites, encysting cells, and the generation of in vitro cysts
Giardia lamblia trophozoites (strain WB, ATCC No. 30957) were cultivated following the

method of Diamond et al (1978) using modified TYI-S-33 medium supplemented with 5% adult bovine
serum and 1% bovine bile (Keister 1983). The antibiotic piperacillin (100 µg/ml) was added during
routine culturing of the parasite (Gillin et al. 1989). Trophozoites were detached from the culture flask
by ice chilling and harvested by centrifugation at 1,500 x g for 10 min at 4 C, washed with PBS and
microscopic determination of cell numbers using a hemocytometer. In vitro encystation was carried out
by culturing the trophozoites in TYI-S-33 medium (pH 7.8) supplemented with adult bovine serum
(10%, v/v), lactic acid (5 mM), and porcine bile (250 mg/ml) for various time points, as described below
(Gillin et al. 1989). Cells were allowed to encyst for 72 h, and cysts were isolated by centrifugation
(2,500 x g for 10 min at 4 oC); washed in distilled water, and kept in water for three days at 4oC. Isolated
water-resistant cysts were counted or subjected to the microscopic experiments also described below.

2.1.3

Overexpression of gGlcT1 in Giardia trophozoites
For overexpression, a small peptide-epitope (AU1)-tagged pNT5 expression plasmid (obtained

from Dr. Chin-Hung Sun, Taiwan) containing gglct1 gene was constructed following the method
described by Pan et al. (Pan et al. 2009). The entire open-reading frame of gglct1 ORF_11642 was
amplified by PCR using the primers 5‘-GCGCCATGGATGGACGGGTTGACTCTCTCC-3‘ and 5‘GCGGAATTCTCAGATGTATCGATACGTATCGTCGAGGGATTTTTT-3‘. The insert was digested
with EcoR1/Nco1 and ligated into EcoR1/Nco1-digested dephosphorylated pNT5 plasmid (Pan et al.
2009). This new plasmid pNT5-gglct1 was then transformed into competent DH5α cells and plated onto
LB plates containing 100μg/ml ampicillin. Colonies were screened by PCR and positive colonies were
sequenced at the University of Texas-El Paso (UTEP) DNA core facility. The ABI Prism BigDye
Terminator v3.1 Cycling Sequencing Kit (Applied Biosystems, Carlsbad, CA) was used to amplify the
DNA with fluorescently labeled dideoxynucleotides. The sequencing reaction was subsequently cleaned
using Agencourt Clean SEQ (Beckman Coulter, Brea, CA). The parasites were placed in a 4-mm
electroporation tube (Fisher Biotech, Waltham, MA) in a 300-μl suspension of TYI-SS media where 40
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μg of the pNT5-gglct1 plasmid was added. Trophozoites were then transfected by electroporation on a
BioRad Gene Pulser X cell (BioRad, Hercules, CA) using the following parameters: 322 V, 500 μF, and
∞Ω resistance (4-mm cuvette). Cells were allowed to recuperate in media overnight, followed by
selection with 150 μg/ml G418 (Sigma Aldrich, St. Louis, MO). Stable transfectant trophozoites
overexpressing gGlcT1 (+gGlcT1) were established within two weeks.

2.1.4

Knockdown of gGlcT1 expression by anti-sense morpholino oligonucleotide
Cultured Giardia trophozoites were harvested by centrifugation as described above. Parasites

were placed in a 4-mm electroporation tube (Fisher Biotech) in a 300-μl suspension of the media,
transfected (using the same setting as the overexpression described above) with anti-GlcT-1 (5‘CTAAGGAGAGAGTCAACCCGTCCAT-3‘),

and

scrambled

(mismatch)

with

(5‘-

CCTCTTACCTCAGTTACAATTTATA-3‘) morpholino oligonucleotides (Gene Tools, Inc., Philomath,
OR) following the protocol described by Carpenter and Candi (2009). gGlcT1 knockdown trophozoites
were resuspended in media and left to recover for 6 h for further experimentation.

2.1.5

Assessing PPMP and morpholino oligonucleotide-treated trophozoites
Giardial trophozoites were electroporated with 50 µM anti-glct1 morpholino and/or treated with

PPMP (10 µM) for 24 h. Cells were then harvested and mounted with Prolong® Gold Antifade Reagent
(Invitrogen) in a four-well chambered slide as described above without any further treatments. At least
100 singlet, doublet and triplet trophozoites from 10 different fields were viewed and counted by
confocal microscopy (Zeiss-LSM 700) using Zen 2009 software (Carl Zeiss, Irvine, CA). The
percentage values of doublet cells were calculated based on the total number cells (singlet, doublet and
triplet).
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2.1.6 Rescue experiments.
The stable transfectants of Giardia trophozoites overexpressing gGlcT1 were generated as
described above. gGlcT1-overexpressing trophozoites were then transfected with anti-gGlcT1
morpholino oligonucleotide following the procedure also described above. After anti-sense morpholino
oligonucleotide transfection, gGlcT1-overexpressing trophozoites were allowed to recover for 6 h before
conducting the experiments described below.

2.1.7

gGlcT1 assay
The activity of the gGlcT1 enzyme in Giardia trophozoites, encysting cells, cysts, gGlcT1-

overexpressing, and -knockdown cells were measured using the methods described for mammalian and
Plasmodium cells (Uchida et al. 2002; Couto et al. 2004). Each reaction tube contained phosphate buffer
(100 mM, pH 7.4), crude enzyme extracts, UDP-[14C]-glucose (~100, 000 cpm/assay), protease
inhibitors (2.5% 1 x protease inhibitor cocktail, 5 µM E-64), 1 mM MgCl2, 5 mM KCl, 2 mM β-NAD,
and the liposomal substrate containing 0.1 nmol of ceramide mixed with dipalmitoylphosphatidylcholine
(DPPC) in a ratio of 1:10 (v/v) (total volume, 100 µl). The mixture was incubated for 5 h at 37 °C and
extracted with chloroform (CHCl3): methanol (MeOH) 1:1 v/v), and the formation of enzymatic product
([14C]-GlcCer) was assessed by measuring the radioactivity in a scintillation counter (Beckman, Brea,
CA). The assay was conducted in the presence and absence of PPMP (10 µM) (Hernandez et al. 2008;
Sonda et al. 2008; Stefanic et al. 2010).

2.1.8

Synthesis of NBD-C6-glucosylceramide
NBD-GlcCer synthesis by Giardia was monitored following the method described by Gupta et

al. (2010). Briefly, cells were harvested and resuspended in PBS supplemented with 1% glucose and
0.2% L-cysteine. A total of 50 µM of NBD-C6 ceramide-BSA complex (Invitrogen) was added and
incubated for 5 h at 37 °C. Sphingolipids were extracted in a solvent in a mixture containing 1.3 ml
acetic acid: MeOH (1:50, v/v), 1.3 ml CHCl3, and 1.3 ml of Milli-Q H2O. The lower-CHCl3 phase was
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pooled and dried under nitrogen. Samples were resolved on TLC (Whatman, Waukesha, WI) using the
following solution: 170 ml CHCl3, 30 ml MeOH, and 2 ml 3.5 (N) ammonium hydroxide (NH4OH).
Formation of NBD-C6-glucosylceramide was visualized under a UV lamp.

2.1.9

Staining with anti-cyst antibody for immunofluorescence
To evaluate the transition from non-encysting to encysting trophozoites and cysts as well as to

identify ESVs, cells were labeled with the following antibodies: mouse anti-cyst antibody (1:100) (Santa
Cruz Biotechnology; Santa Cruz, CA), rabbit anti-GlcT1 custom antibody (1:200) (Thermofisher
Scientific), TMR-conjugated goat anti-mouse antibody (1:500) (Invitrogen), Fluorescein-conjugated
goat anti-mouse antibody (1:500) and goat anti-rabbit Alexa Fluor 594 (1:500). The anti-cyst antibody
was raised against intact cysts and therefore recognizes all cyst wall proteins (CWP1, CWP2 and
CWP3). Trophozoites were cultivated and subjected to encystation in a cultured medium as described
before (Gillin et al. 1989). Cells were harvested and fixed to four-chambered slides using 4%
paraformaldehyde. Fixed samples were allowed to react with anti-cyst and anti-GlcT1 antibody
overnight at 6–10oC, followed by reacting with corresponding secondary antibody for 2 h at room
temperature. Cells were subsequently mounted with Prolong® Gold Antifade Reagent mixed with 4', 6diamidino-2-phenylindole (DAPI; Invitrogen). Samples were analyzed in a confocal microscope (Carl
Zeiss Laser Scanning Systems LSM 700), using the Zen 2009 software (Carl Zeiss) for acquisition and
image analysis.

2.1.10

Glycosphingolipid analysis by ESI-MS-MS
Neutral and acidic glycosphingolipids (GSLs) were extracted and separated following the

method described by Li et al (2008). Briefly, control, gGlcT1-overexpressed, -knockdown and -rescued
trophozoites (~1x109 cells/sample) were harvested, pelleted, and extracted first with CHCl3: MeOH (1:1,
v/v) and then with isopropanol: hexane:H2O (55:25:20, v/v/v) before being subjected to DEAESephadex chromatography. Neutral lipids were eluted with CHCl3: MeOH: H2O (30:60:8, v/v/v).
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Acidic lipids were eluted with MeOH-containing 0.8 M sodium acetate. Both neutral and acidic GSLs
were subjected to methylation as described by Ciucanu and Kerek (1984), followed by ESI-MS/MS
analysis using an LTQ XL, Thermo Fisher Scientific). Briefly, samples were spiked with 1 pmol/µl
methylated standards (d18:1/C12:0) and introduced via a TriVersa NanoMate nanoelectrospray source
(Advion, Ithaca, NY) (capillary temperature 230 °C, with injection time of 100.00 ms, activation time
of 30 ms, activation Q-value of 0.250, isolation width of m/z 2.0, and acquisition time of 0.5 min).
Quantitation was achieved using select-reaction monitoring (SRM) with collision energy set to 50 for all
samples. For hexosylceramide reactions, singly charged parent ions with sodium adduct ([M+Na+]+)
were fragmented and monitored for the fragment ions of permethylated hexose [C10H20O6+Na]+ (from
monohexosylceramide), permethylated dihexose [C19H36O11+Na+]+ (from dihexosylceramide), or
permethylated trihexose [C28H52O16+Na+]+ (from trihexosylceramide). For the acidic GSLs (i.e., GM1,
GM3, and GD3), the loss of methylated-sialic acid fragment at 376 Da was monitored
[M+Na+]+/[M+Na-C17H30NO8]. Hexosylceramide was normalized to the internal standard d18:1/C12:0glucosylceramide (Avanti Polar Lipids), and dihexosylceramide and trihexosylceramide were
normalized to the internal standard d18:1/C12:0-lactosylceramide (Avanti Polar Lipids). GM3, GD3,
and GM1 were normalized to [13C]-deuterated d18:1/C18:0-GM3 standard (obtained from Matreya).
Due to differences in ionization efficiencies between individual lipids, relative abundance was
calculated rather than absolute mass of each lipid class.

2.1.11

Monitoring cyst viability
Fluorescein diacetate (FDA) inclusion and propidium iodide (PI) exclusion experiments were

performed to monitor cyst viability. Briefly, a 25-mM stock solution of FDA and PI (Sigma Aldrich)
were prepared in 100 mM phosphate buffer (pH 6.0), from which a working solution was made by
adding 40 μl of stock to 10 ml phosphate buffer. gGlcT1-overexpressing and -knockdown trophozoites
were subjected to encystation as described above, and the water-resistant cysts were collected by
centrifugation. Approximately, 107 cysts were subjected to FDA and PI staining as described previously
by Gillin et al. (1989). Cysts were then washed with PBS and mounted on a slide with DAKO mounting
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media (DAKO, Carpinteria, CA) and viewed under the Zeiss LSM 700 Confocal microscope using Zen
2009 software (Carl Zeiss).

2.1.12

Western blot analysis
Parasites were harvested and resuspended in lysis buffer (5mM Tris HCl; EDTA 2mM; Triton X-

100; 0.1%; pH 7.4) containing protease inhibitor cocktail and E-64 (1 µM, Sigma). The sample was
freeze thawed at -80 °C, boiled in sample buffer before being analyzed (40 µg protein/lane) by 10%
SDS-PAGE, and was followed by immunoblotting analysis on the polyvinylidene fluoride (PVDF)
membrane. The membrane was blocked in 1% BSA, incubated with anti-cyst antibody (monoclonal,
1:100) or anti-gGlcT1 antibody (polyclonal, 1:200) (Thermo Fisher Scientific) and incubated overnight
at 4 °C. The PVDF membrane was then incubated with anti-mouse HRP conjugate (1:10,000; KPL, Inc.,
Washington, DC) or anti-rabbit HRP conjugate (1:5,000 [GlcT1]; KPL, Inc., Washington, DC) for 30
min at room temperature. The enhanced chemi-luminescence (ECL) technique was used for the
detection of protein bands.

2.1.13 Statistical analysis
All values were given as mean values ± S.D., and statistical analyses were generated using SAS
software

ver.

9.2

(SAS

Institute,

Cary,

NC)

and

Graphpad

QuickCalcs

(http://www.graphpad.com/quickcalcs/). In experiments with three or more variables, the F-test was
performed, and in experiments with two variables the Student’s t-test was performed. Statistical values
less than 0.01 were considered highly significant, whereas values less than 0.05 were considered
significant.
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2.2 RESULTS

2.2.1 Giardial GlcT1 activity is stimulated at the time of encystation and reached maximum in
mature cysts:
Earlier reports from this and other laboratories have indicated that GlcCer, a precursor for a wide
variety of GSLs, plays an important role during encystation by Giardia (Hernandez et al. 2008; Sonda et
al. 2008). It was observed that (i) the transcript of gGlcT1 gene (gglct1) is upregulated in encysting cells
and (ii) PPMP, an inhibitor of GlcCer synthesis (Shukla et al. 1991; Kovacs et al. 2000), inhibits the cyst
production in culture. In the current study, we asked if Giardia synthesizes the active gGlcT1 enzyme
and uses it to drive the process of encystation. Therefore, gGlcT1 activity was measured in the cell-free
extracts (1500 x g-supernatant) of non-encysting and encysting trophozoites as well as in water-resistant
cysts using UDP-[14C]-glucose and ceramide (Uchida et al. 2002; Couto et al. 2004). Results show that
the basal gGlcT1 activity is low in non-encysting trophozoites and upregulated in 12- and 24-h
encysting cells and increases several-fold in cysts (Fig. 4A). It was found that the gGlcT1 activities in
trophozoites and encysting cells were inhibited by PPMP which bears a resemblance to both ceramide
and GlcCer (Shukla et al. 1991; Kovacs et al. 2000). However, unlike trophozoites and encysting cells,
the cyst enzyme was completely resistant to PPMP (Fig. 4A). Next, we generated GlcT1-knockdown
Giardia where the gglct1 gene was silenced by morpholino oligonucleotide. Knockdown by morpholino
analogues is a faster and more efficient way to silence genes in Giardia (Carpenter et al. 2009). In recent
years, various laboratories have successfully used anti-sense morpholino oligonucleotides to knockdown
giardial kinesin and flagellar genes. The effects of anti-sense morpholinos are transient and last
approximately 72 h, which is sufficient to carry out one round of the encystation cycle (Carpenter et al.
2009; House et al. 2011). As shown in Fig. 4B, knockdown by anti-gGlcT1 morpholino reduced the
gGlcT1 activity in cysts by ~60%. This result suggests that although resistant to PPMP, cyst gGlcT1
could be inhibited by anti-gglct1 morpholino blocking the translation initiation of gGlcT1 by targeting
the 5' region of the gglct1 gene. On the other hand, PPMP competes with ceramide for the catalytic site
of gGlcT1 and is thereby expected to inhibit the enzymatic reaction (Kovacs et al. 2000).
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Synthesis of GlcCer, the reaction product of gGlcT1 was also monitored by assessing NBD-GlcCer
synthesis by encysting cells. Both non-encysting and encysting Giardia trophozoites were labeled with
NBD-C6-ceramide, and the product was analyzed by TLC. Fig. 4C shows that the synthesis of NBDGlcCer is extremely low (almost non-visible in the photograph) in trophozoites and increases during
encystation. However, it was found that the formation of NBD-GlcCer in 12-h encysting cells is slightly
higher than in 24-h encysting cells, which could be due to the fact that cells at the later stage of
encystation (i.e., 18 h onwards) start forming cyst walls and become increasingly impermeable to NBDceramide and other molecules (data not shown). Therefore, no attempt was made to label the cyst with
NBD-GlcCer. The increased synthesis of NBD-GlcCer during 12 h- and 24-h encysting Giardia
supports our enzymatic results (Fig. 4C) that encystation stimuli induce gGlcT1 activity, leading to the
synthesis of GlcCer.
Western Blot analyses with anti-gGlcT1 antibodies (custom ordered from Thermofisher) was
performed to determine the protein expression levels during encystation (Fig 5D). The antibodies were
observed on immunoblot and showed that GlcT1 labels proteins approximately ~30 and ~50 kD and the
labeling increases as encystation progresses, which matches with the enzyme data (Fig.4A). When
antibodies were pre-treated with their respective peptide antigens, no antibody-antigen reactions were
observed, further demonstrating the specificity of the anti-gGlcT1 antibody.
Next, we proceeded with immunofluorescence of gGlcT1 custom antibody (Thermofisher
Scientific). Giardial trophozoites, 24h encysting cells, and complete cysts were stained with both
gGlcT1 and CWP antibodies. In trophozoites (Fig 5A), there is no CWP labeling but gGlcT1 forms
vesicle-like aggregates that are cytoplasmic. In 24h encysting cells (Fig 5B), CWP antibodies label the
ESVs that transport cyst wall material to the plasma membrane. On the other hand, gGlcT1 continues to
label the vesicle-like structures, but they do not localize with the ESVs. Moreover, in encysting cells,
gGlcT1 begins to localize between the nuclei where basal bodies and central mitosomes are located.
When cyst wall is completely formed (Fig 5C), gGlcT1 is again cytoplasmic and shows no uniform
localization pattern.
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Figure 4: gGlcT1 activity in encysting Giardia.
A) gGlcT1 activity in nonencysting, encysting (12- and 24-h), and water-resistant cysts was
measured in the cell-free extracts using [14C]UDP-glucose (100,000 cpm/assay) and ceramide as
substrates. The levels of glycosphingolipids increase with encystation while PPMP inhibits its
formation. Only in cysts is PPMP ineffective. Data represent means S.D. of three separate experiments,
and the experiments were carried out in duplicate (**, p < 0.01). B) activity of gGlcT1 in control,
PPMP-treated, and gGlcT1- knockdown cysts. Control and anti-gGlcT1 morpholino-transfected
trophozoites were subjected to encystation. To assess the effect of the inhibitor, PPMP (10 µM) was
added to the assay mixture. Again, although PPMP had no effect on glycosphingolipid formation in
cysts, anti-gGlcT1 morpholino oligo suppressed the activity. The data represent means S.D. of three
separate experiments (**, p<0.01). C) synthesis of NBD-GlcCer by encysting (12 and 24 h)
trophozoites. Live cells were labeled with NBD-ceramide and sphingolipids were extracted and

24

analyzed by TLC. The data shows that GlcCer formation increases with encystation. The experiment
was carried out three times, and the representative result from a single experiment is shown here.
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D

Figure 5: Immunofluorescence and western blot analysis of gGlcT1 custom antibodies
Giardial trophozoites (panel A), 24h encysting cells (panel B), and complete cysts (panel C) were
fixed, and treated with both GlcT1 and CWP antibodies. In trophozoites, there is no CWP labeling but
GlcT1 forms vesicle-like aggregates that are cytoplasmic. In 24h encysting cells, CWP antibodies label
the ESVs that transport cyst wall material to the plasma membrane. On the other hand, GlcT1 continues
to label the vesicle-like structures, but they do not localize with the ESVs. Moreover, GlcT1 begins to
localize between the nuclei in encysting cells where basal bodies and central mitosomes are located.
When cyst wall is completely formed, GlcT1 is again cytoplasmic and shows no uniform localization
pattern. Purified polyclonal rabbit antibodies were also observed on immunoblot (panel D) and showed
that GlcT1 labels proteins approximately ~30 and ~50 kD and the labeling increases as encystation
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progresses. When blocked with peptide, no proteins were detected showing the specificity of the
antibody.
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2.2.2

The biogenesis of encystation-specific vesicles is modulated by gGlcT1 activity:
Giardia has a relatively simple life cycle—i.e., replicative trophozoites and relatively dormant

cysts. During encystation in the small intestine, trophozoites synthesize ESVs which are necessary to
transport CWPs to plasma membranes (Bittencourt-Silvestre et al. 2010). ESVs are synthesized in the
endoplasmic reticulum (ER) located in the perinuclear membranes/cytoplasm in early encysting cells,
and then distributed extensively in the periphery of the cell (in close proximity to peripheral vacuoles) in
the late encystation phase (McCaffery et al. 1994). Because of the presence of Golgi-like cisternae in
ESVs, these sorting vesicles are also considered as a primitive Golgi complex of Giardia (Stefanic et al.
2009). Over the years, many investigators have studied encystation and identified various proteins and
genes that are associated with the process (Lauwaet et al. 2007). However, nothing is known about how
the ESV biosynthesis is regulated and participates in viable and infective cyst formation. Because
gGlcT1 activity is upregulated during encystation (Fig. 4A), it was thought that gGlcT1 was linked to
ESV biogenesis. To test this, control and gGlcT1-knockdown trophozoites were subjected to encystation
for 18 h and ESV synthesis was monitored using an anti-cyst antibody that recognizes early and late
ESVs as well as the cyst walls (Hehl et al. 2004). It was observed that anti-gGlcT1 morpholino
oligonucletide, which inhibited gGlcT1 activities in trophozoites and cysts was found to block ESV
biogenesis completely (Fig. 6B). On the other hand, ESV synthesis by encysting cells that were
transfected with scrambled morpholino oligonucleotide (labeled as control [scrambled] in Fig. 6A) was
not affected at all. To further elucidate the role of gGlcT1 in ESV biogenesis, we overexpressed the
gglct1 gene in trophozoites and subjected them to encystation. Fig. 6D shows that gglct1 overexpression
produces aggregated and enlarged ESVs as compared with control cells that were transfected with empty
plasmid. This indicates that the modulation of gGlcT1 activity either by knockdown or overexpression
affects ESV biosynthesis in Giardia.
Fig. 7A demonstrates that gGlcT1 activity in overexpressed trophozoites increased ~3 fold as
compared with the activity present in control trophozoites (i.e., specific activities increased from 0.5
pmol/min/mg protein in control to 1.4 pmol/min/mg protein in gGlcT1-overexpressing cells).
Knockdown by anti-gglct1 morpholino oligonucleotide inhibits gGlcT1 activity in trophozoites by
~50% (from 0.5 pmol/min/mg protein to 0.24 pmol/min/mg protein). Furthermore, the rescue
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experiment (i.e., transfecting gGlcT1-overexpressing trophozoites with anti-gglct1 morpholino
oligonucleotide) lowered the gGlcT1 activity by ~40%. Fig. 7B demonstrates that overexpression of
gGlcT1 in non-encysting trophozoites causes an increased synthesis of NBD-GlcCer, further suggesting
that gGlcT1 activity is directly linked to GlcCer synthesis in Giardia.
Next, we asked whether gGlcT1 modulation by overexpression and knockdown also affects the GSL
profiles in Giardia. For this, lipids were extracted from overexpressed, knockdown, and rescued
trophozoites and subjected to ESI-MS/MS analysis as described in experimental procedures. Using totalion map and precursor-ion scans we identified both neutral and acidic GSLs that were present in control
and gGlcT1-modulated trophozoites. Among the neutral lipids, mono-, di-, and tri-hexosylceramides
were identified and found to be altered by gGlcT1 modulation. While gGlcT1 overexpression increased
the amount of mono-hexosylceramide by ~28 fold, the effect was somewhat less (~ 2 fold) on dihexosylceramides. Interestingly, no effects of gGlcT1 overexpression were observed in the case of trihexosylceramides (Fig. 7C). gGlcT1 knockdown, however, elevated the level of monohexosylceramides (~5 fold) and the rescue experiment had no effect, i.e., same as the knockdown (Fig.
3C). Knockdown also decreased the levels of di- and tri-hexosylceramide slightly and rescue treatment
appeared to reverse these effects (Fig. 7C). The analysis of acidic fractions revealed that GM1, GM3,
and GD3 lipids are present in control, overexpressed, knockdown, and rescued trophozoites; however,
the changes of their levels were not consistent with gGlcT1modulation (not shown).
Because ESV synthesis is linked to gGlcT1 activity (Fig. 6), and the fact that PPMP blocks
encystation (Hernandez et al. 2008; Sonda et al. 2008), we asked if the modulation of gGlcT1 activity
(shown in Fig. 8) also regulates ESV biogenesis. Photographs Fig. 8A, b and Fig. 8A, c demonstrate that
while gGlcT1 overexpression induces the synthesis of aggregated and enlarged ESVs, knockdown of
gGlcT1 activity by anti-gglct1 morpholino oligonucleotide completely blocks ESV synthesis. More
interestingly, the rescue experiment reverses the effects of overexpression and knockdown and generates
ESVs (Fig. 8A, d) that are comparable to control cells (Fig. 8A, a). Again, Fig. 8A, e represents ESVs
generated by encysting cells that were treated with scrambled morpholino oligonucleotide, which shows
the similar pattern of ESVs found in non-transfected control encysting cells shown in Fig. 8A a.
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Analysis of individual ESVs are shown in Fig. 8B, demonstrating that gGlcT1 overexpression increases
the perimeters and areas of ESVs by ~6- and ~10 fold, respectively. The perimeter and area analyses of
individual ESVs were carried out with the help of Zeiss Zen 2009 software (Carl Zeiss) as shown in Fig.
4C.
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Figure 6: Knockdown and overexpression of gGlcT1 affects ESV biogenesis
Giardia trophozoites were transfected with anti-gGlcT1 morpholino oligonucleotide (50 M) (23)
and subjected to encystation for 24 h before ESVs were analyzed by confocal microscopy. Control
trophozoites (panel A) were transfected with a scrambled morpholino oligonucleotide sequence (50 M)
supplied by the manufacturer. Discrete ESVs are visible in control cells but are not present in antigGlcT1 morpholino-transfected (i.e. gGlcT1 knockdown) cells (panel B). Arrows show ESVs, and
arrowheads indicate nuclei. Bar, 10 m. B, gGlcT1- overexpressing (gGlcT1) trophozoites (panel D) were
subjected to encystation for 24 h, and ESVs were analyzed as described above. gGlcT1 overexpression
causes an aggregation/enlargement of the ESVs when compared with control cells that were transfected
with empty plasmids (panel C). Arrows show ESVs, and arrowheads indicate nuclei. Bar, 10 m. Inset
shows the magnified images of ESVs.
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are from a single study. C) ESI-MS/MS analysis of GSLs. GSLs from control (containing empty
plasmid) with, gGlcT1-knockdown (KD), overexpressed (+GlcT1), and rescued trophozoites were
extracted and analyzed. Mono-hexosylceramide (HexCer), di-hexosylceramide (di-HexCer); trihexosylceramide (tri-HexCer); the results (pmol/106 cells) presented here are the mean of fold changes
(compared with control trophozoites) S.D. of three technical replicates (*, p < 0.05; ***, p < 0.001). D)
trophozoites expressing AU1-tagged gGlcT1 were monitored by reacting with anti-AU1 antibody
followed by labeling with FITC-conjugated anti-mouse antibody and examination under an
immunofluorescence confocal microscope. The figure shows that overexpressed gGlcT1-AU1 (shown
as+gGlcT1 in the figure) forms structures that are granular, aggregated, and localized throughout the
cytoplasm and, to some extent, in the perinuclear regions. However, the overexpressed gGlcT1 granules
are also localized in the ventral groove and lateral shield areas of the trophozoites. White arrowheads
indicate DAPI-stained nuclei (control) and long yellow arrowheads denote ventral groove (vg), lateral
shield (ls), and plasma membrane (pm) in overexpressed trophozoites. Bar, 10 µm.
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Figure 8: Modulation of gGlcT1 activity affects ESV biogenesis in Giardia
A, ESV production was monitored in the following:(panel a, control; panel b,GlcT1overexpressing (+gGlcT1); panel c, antisense, morpholino oligonucleotide-treated gGlcT1-knockdown
cells; panel d, rescued cells, and panel e, cells transfected with scrambled morpholino oligonucleotides.
Arrows indicate ESVs, and arrowheads denote nuclei. Bar, 10m. B and C, changes of perimeters and
areas of ESVs are shown in the bar graphs. gGlcT1 overexpressed encysting cells formed ESVs with a
significantly larger area and perimeter. This morphology of ESVs reverted back to normal when
gGlcT1-overexpressed cells were resxued with anti-gGlcT1 morpholinos. The analyses were carried out
by measuring the perimeters and the areas of individual ESVs using Zeiss Zen 2009 confocal software.
*, p < 0.05; **, p < 0.01.
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2.2.3. Unlike PPMP, anti-gGlcT1 morpholino oligonucleotide does not affect cell replication of
Giardia trophozoites:

PPMP is a common inhibitor of gGlcT1 enzyme that has been extensively used to evaluate GlcCer
functions in various organisms (Kovacs et al. 2000). It has been reported that PPMP blocks replication
and cytokinesis of giardial trophozoite and thereby thought to inhibit the encystation and cyst production
in culture (Sonda et al. 2008; Stefanic et al. 2010). We have shown earlier that PPMP interferes with the
formation of cysts when it is added in the culture medium during encystation (Hernandez et al. 2008).
Because our current results show that anti-gglct1 morpholino oligonucleotide inhibits gGlcT1 activity
and ESV biogenesis (Figs. 4 and 6), and because the activity of this enzyme is low in trophozoites and
upregulated in encysting cells, we thought that the effect of PPMP-inhibiting replication and cytokinesis
on non-encysting trophozoites might not occur via GlcCer synthesis, as previously thought (Sonda et al.
2008; Stefanic et al. 2010). In fact, there are reports in which PDMP (an analogue of PPMP) has been
shown to block cell-cycle progression in mammalian cells by inhibiting cyclin-dependent kinases, which
could be independent of gGlcT1 inhibition and ceramide accumulation (Rani et al. 1995). To address
this possibility in Giardia, trophozoites were transfected with morpholino oligonucleotide (anti-glct1)
and the growth was measured as shown in Fig. 9A. Side by side, the growth of the trophozoites in the
presence of PPMP (10 µM) was also conducted, and the results showed that while PPMP affects the
growth of trophozoites, anti-gglct1 morpholino exhibits no effects (Fig. 9A). Fig. 9B, b demonstrates
that PPMP, as shown earlier (Sonda et al. 2008), blocks the replication of trophozoites and generates
undivided-doublet cells. In contrast, anti-gglct1 morpholino did not affect the replication of trophozoites
(Fig. 9B, c). When morpholino-transfected, gGlcT1-knockdown trophozoites were treated with PPMP,
the formation of undivided doublets was observed again (Fig. 9B, d). The analysis revealed that while
~25% of trophozoites form undivided doublets after PPMP treatment, less than ~5% of doublets were
observed in control and anti-gglct1 morpholino-treated trophozoites (Fig. 9C). The combined effect of
anti-gglct1 morpholino and PPMP generated ~20% doublets, as shown in Fig. 9C. These results indicate
that PPMP may not act via gGlcT1 in Giardia and that the blocking of cytokinesis in trophozoites by
this inhibitor could be through other mechanisms.
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Figure 9: Effects of PPMP and anti-gGlcT1 morpholino on growth and replication of trophozoites
A) Assessing the growth of trophozoites. Approximately 2X105 cells were inoculated into 4-ml
tubes containing TYI-S-33 medium, pH 7.1. Trophozoites were allowed to grow for 35 h (the doubling
time of trophozoites is ~7 h) and were counted under a microscope. Control and Morpholino-treated
cells maintained a normal growth rate whereas the cells treated with PPMP had slow growth. Each
experiment was carried out in triplicate, and the experiment was repeated three times. B) Differential
interference contrast confocal images show the effects of anti-gGlcT1 morpholino oligonucleotide and
PPMP on cell division and cytokinesis. Nuclei were stained with DAPI. Control, panel a; 10µM PPMP,
panel b; knockdown with morpholino, panel c; morpholino + PPMP cells, panel d. C) Quantitative
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assessment (e.g. microscopic counts) of doublet trophozoites that are produced by control, PPMPtreated, anti-gGlcT1 morpholino-induced knockdown trophozoites (knockdown) and knockdown (KD)
trophozoites + PPMP. At least 100 singlet, doublet, and triplet (the number of undivided triplet
trophozoites were small and therefore are not shown in the figure) trophozoites from 10 different fields
were viewed and counted under the Zeiss LSM 700 confocal microscope using Zen 2009 software. The
percentage values of doublet cells were calculated based on the total number of singlet, doublet, and
triplet cells. *, p < 0.05; **, p < 0.01.
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2.2.4

Regulated expression of gGlcT1 is critical for maintain the cyst viability:
The production of viable cysts is essential for Giardia to establish infection in the small intestine

of humans. Earlier reports suggested that cyst morphology is directly correlated with cyst viability and
only viable cysts of Giardia produce infection in mice (Schupp et al. 1987; Schupp et al. 1987). Gillin et
al. (1989) reported that in vitro-derived G. lamblia cysts are of two kinds—i.e., Type I and Type II. The
Type I cysts are oval-shaped with uniform and refractive cyst walls, being mostly (~90%) viable. In
contrast, Type II cysts lack the morphological characteristics of Type I and a majority (~70%) of them
are non-viable. In a heterogeneous cyst population (i.e., a population composed of both Type I and Type
II cysts), ~10-30% of cysts exhibit Type I morphology (Gillin et al. 1989; Boucher et al. 1990). Because
we found that the gGlcT1 activity increased during encystation (Fig. 4) and that the modulation of its
function (by overexpression and knockdown) regulated ESV biogenesis (Figs. 4 and 6), we asked
whether gGlcT1 activity is also important for maintaining the cyst morphology and viability. Therefore,
trophozoites from various conditions—i.e., control, and gGlcT1-overexpressing, -knockdown, and rescued—were subjected to encystation for 72 h, and the cysts were isolated by centrifugation as
described in the experimental section. Fig. 10A, a shows control cysts with Type I morphology that
react with the anti-cyst antibody, which labels the oval-shaped cyst wall. However, this changes
significantly in gGlcT1-overexpressing and -knockdown cells (Figs. 10A, b, and 10A, c). Cysts
produced by gGlcT1-overexpressing cells appear to be Type II because they are incomplete, clustered,
have thin cyst walls, and show minimum reactivity to anti-cyst antibody. Knockdown of gGlcT1 also
produces aggregated cryptic cysts; the majority of these cyst-like structures exhibit no reaction to anticyst-wall antibody. The rescue treatment, shown in Fig. 10A, d, however, produces cysts with wellformed cyst walls that react with the cyst antibody. Because the morphology could be an indicative of
viability (Schupp et al. 1987; Boucher et al. 1990), our next goal was to test if the viability of cysts is
affected by gGlcT1-overexpression and -knockdown. The viable and non-viable cysts were identified by
staining with fluorogenic dyes—i.e., cell permeable esterase-substrate fluorescein diacetate (FDA) and
the cell impermeant nucleic-acid stain propidium iodide (PI), which were earlier used by other
laboratories to determine the viability of giardial cysts (Schupp et al. 1987; Schupp et al. 1987; Gillin et
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al. 1989). Fig. 10B indicates that while in control samples ~12% of cysts were viable, only ~8% and
~3% of cysts were viable in gGlcT1-overexpressing and -knockdown cells, respectively. Most
importantly, the rescue experiment, in which the effect of gGlcT1 was neutralized by anti-gGlcT1
morpholino analogue, recovers the cyst and increases the viability up to ~10%. This is an important
observation and strongly suggests that gGlcT1 activity in Giardia not only regulates ESV biogenesis but
also maintains the cyst viability. Although it appears that these numbers of viable cysts are somewhat
low, our calculation is based on the total number of water-resistant cysts that contain all type of cysts,
including Type I and Type II. Thus, viability estimations, shown here, are within the expected range and
in accordance with the report published by Gillin et al. (1989) and Boucher et al. (1990).

2.3 CONCLUSION
Glycospingholipids (GSLs) are known to participate in various cellular functions, including
differentiation, signaling, and apoptosis. GlcCer, an important GSL, is involved in inducing the drugresistance phenomenon in cancer cells, as well as determining fungal pathogenesis and the formation of
Polycystic Kidney Disease in humans (ref). In Giardia, I found that GlcCer plays an important role in
generating viable cysts. In Chapter 1, I showed for the first time that the activity of gGlcT1 (which
catalyzes the synthesis of GlcCer) increases during encystation. PPMP has been found to inhibit gGlcT1
activity in trophozoites and early encysting cells, but it is not effective in reducing the activity of the
cyst gGlcT1. When gGlcT1 activity was modulated by using the overexpression and knockdown of the
gglct1 gene, I found that ESV biogenesis is affected. Contrary to previous reports (Sonda et al. 2008;
Steffanic et al. 2010), I have demonstrated that PPMP is active during encystation but not in the nonencysting stages of the parasitic life cycle. Most importantly, it was observed that the regulated
expression of gGlcT1 is important for maintaining cyst viability. This study will set the stage for future
investigations to develop potential therapies targeting GlcCer biosynthesis in Giardia. In recent years,
efforts have been underway to produce a vaccine against Giardia trophozoites (Rivero et al. 2010), and
so my results should provide valuable information about whether gGlcT1 knockdown-attenuated cysts
with reduced viability could be used as a live vaccine candidate against giardiasis in the future.
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Figure 10: gGlcT1 activity regulates the morphology and viability of in vitro-derived cysts
A) trophozoites were subjected to encystation for 72 h. Cysts were harvested and treated with
anti-cyst antibody to be examined under differential interference contrast and confocal microscopy.
Panel a, control. Panel b, gGlcT1-overexpressing (+gGlcT1); panel c, gGlcT1-knockdown; and panel d,
rescued. Arrows indicate the cyst wall. Cyst nuclei were stained with DAPI. gGlcT1-overexpressed and
knockdown cells form broken and incomplete cysts compared to control, meanwhile rescue cysts form
control-like cysts. Bar, 10 µm. B) Testing the same cyst samples (shown in A) for viability using FDA
40

and PI stains. The cells were also analyzed using differential interference contrast and confocal
microscopy with green indicating live and red denoting dead cysts. Panel e, control; panel f, +gGlcT1;
panel g, gGlcT1 knockdown, and panel h, rescued. Bar, 10 µm. C) Quantification of the viability assay.
Approximately 100–150 cysts were examined from 5 to 10 different fields to identify and count the
viable cysts. Viability in +GlcT1 and knockdown cysts are lower than control. However, the viability of
rescue cysts increases slightly to control levels. The results were presented in mean values ±S.D. of
three separate experiments conducted in different days with different sample preparations. *, p < 0.05.
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Chapter 3: Glucosylceramide Transferase regulates ESV biogenesis and cyst
viability by maintaining the lipid homeostasis in Giardia
The encystation-specific vesicles (ESVs) are considered post-ER or transient Golgi organelles
that transport all cyst-wall materials to the plasma membrane of trophozoites. Usually, these vesicles are
round and enclosed by bilayered membranes (Lanfredi-Rangel et al. 2003). When they reach the plasma
membranes carrying CWPs, these vesicles fuse with the membranes and release all their contents to
form solid and protective cyst walls. Thus, proper integration of ESVs to plasma membranes is critical
for cyst-wall biogenesis and the production of viable and infective cysts. Because my results in Chapter
2 show that the modulation of gGlcT1 activity (by overexpression, knockdown, and rescue) affects ESV
biogenesis and cyst viability, and because gGlcT1 overexpression produces enlarged ESVs and nonviable cysts, I thought that gGlcT1 could be linked to the uptake and maintenance of the overall of
balance of lipids in Giardia and that changing this balance might produce abnormal ESVs and noninfective cysts.
As far as giardial lipid metabolism is concerned, earlier studies have indicated that this parasite
has limited lipid synthesis ability and that the majority of its lipids and fatty acids are obtained from the
culture medium, of which the two major ingredients are bovine serum and bile. The serum and bile
provide essential lipids to Giardia, including phospholipids, cholesterol, fatty acids, and sphingolipids.
We have also reported earlier that although Giardia is dependent completely on exogenous lipids it has
the ability to generate selective membrane lipids that are not present in the medium (reviewed by Yichoy
et al. 2011). Studies from our laboratory indicate that phospatidylcoline (PC) and phosphatidylglycerol
(PG) are the major phospholipids in Giardia. Mass spectrometric analysis revealed that at least 17 and
19 different species of PGs and PCs, respectively, are present in this parasite, along with various
combinations of odd- and even-numbered, carbon-containing fatty acids. In addition to the PGs and PCs,
6 species of phosphatidylethanolamines (PEs), 3 species of sphingomyelin (SMs), and 2 species of
phosphatidylinositols (PIs) were also present. It is interesting that except for PGs and PEs all
phospholipids are obtained from the growth medium, which means that it is likely that PGs and PEs are
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newly synthesized phospholipids in Giardia (Yichoy et al. 2009). Sphingolipidomic analysis indicated
that sphingomyelin; mono-, di- and, tri-hexosylceramides; and gangliosides (GM1, GM3, and GD3) are
the major GSLs found in this organism. These GSLs display profiles similar to those present in the
serum (except for some variations that we found in fatty-acid chain lengths; Duarte et al., manuscript in
preparation).
Therefore, the lipid metabolism in Giardia is a complex scenario in which the parasite takes up
the majority of its lipids from the medium and synthesizes or assembles a few. It is not well understood
how these two separate events (i.e., uptake and de novo synthesis/assembly) are coordinated and utilized
for ESV biogenesis and cyst production. To answer some of these questions, and to understand how
lipid metabolism is regulated by gGlcT1, I overexpressed gglct1 gene and investigated lipid
internalization and membrane fluidity by Giardia trophozoites.
3.1 MATERIALS AND METHODS
3.1.1 Determination of mRNA levels of giardial lipid genes by quantitative reverse transcriptionPCR (qRT-PCR)
To determine whether the mRNA expression of various lipid genes are altered in gGlcT1
overexpressed Giardia, RNA from encysting and non-encysting trophozoites as well as from waterresistant cysts were extracted using TRIzol reagent (Invitrogen, Carlsbad, CA). cDNA was synthesized
by using 2µg of purified RNA with the iscript cDNA synthesis kit (BioRad). 2μl of a 1:20 dilution of
cDNA was mixed with 10μl of SYBR Green Master Mix (Applied Biosystems, Foster City, CA), the
primers for the genes of interest (1μl each) and run through the MyiQ Thermal Cycler using the
following parameters: 95°C 15min, 55 X (95°C: 30 sec, 55°C: 30 sec, 72°C: 30 sec), 72°C: 5 min and
60°C: 30 sec for melt curve. Tubulin was used as a housekeeping gene the relative standard curve
method was used to quantify transcript levels. For the list of primers that were analyzed are shown in
Table-1.
3.1.2 Sterol analysis by GC-MS
Sterol analysis in control and gGlcT1-overexpressing trophozoites was carried out according to
the method of Fridberg et al. (2008). Trophozoites (~1x108) were grown and harvested as described
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above; resuspended in CHCl3: MeOH: H2O (1:2:0.8, v/v/v), and centrifuged (1500 x g) at room
temperature for 15 min. The supernatant was collected and dried under nitrogen, and the pellet was then
extracted with CHCl3: MeOH (2:1, v/v) three times and with CHCl3: MeOH: H2O (1:2:0.8, v/v/v) twice
before being dried under a nitrogen stream. The supernatants obtained from these six extractions were
pooled together before being dried in the same flask. The dried samples were then submitted to Folch’s
partition, being first diluted in CHCl3: MeOH: H2O (4:2:1.5, v/v/v), and then centrifuged (1500 x g) at
room temperature for 15 min. This partitioning gave rise to two phases: a lower phase, rich in free fatty
acids, sterols, and phospholipids, and an upper phase, rich in inositolphospholipids. The lower phase
was dried down with nitrogen gas, resuspended in pure CHCl3, and fractionated through a silica-gel 60
column according to Pernet et al. (2006). The CHCl3 phase of the samples were dried under a nitrogen
stream and dissolved in dichloromethane. Fifty ng of external standard (Stigmasterol, Sigma Aldrich)
was added to the giardial sample and 1 µl of the resulting mixture was injected into the gas
chromatographer (Trace GC, Thermo Fisher Scientific) coupled to a mass spectrometer (Polaris Q,
Thermo Fisher Scientific) (GC-MS). The fractionation was performed in a TR-5-ms column (30 m x 250
mm x 0.25 µm, Thermo Fisher Scientific). The injector temperature was set at 250 °C. The gradient was
set at an initial temperature of 170 °C for 3 min, followed by a 20 °C /min increase up to 280 °C, and
then a 17-min hold after the final temperature was achieved. The carrier gas was helium, with a flow rate
of 1.2 ml/min. The samples were ionized by electron impact (EI) at 70 eV and 30 °C, and the spectra
were collected at the 50–650 m/z range.
3.1.3 Fatty acid methylation and GC-MS analysis
Fatty acids extracted from Giardia were subjected to methylation following the protocol
described by Maldonado et al. (2006). Briefly, a methanol fraction of lipid extracts from trophozoites
(~1x108) was dried under nitrogen and resuspended in 13 (N) NH4OH: MeOH (1:1, v/v) and incubated
for 1 h at 37 °C. The sample was then dried under a nitrogen stream, resuspended in MeOH, dried again,
and mixed with 0.5 (N) methanolic HCl. The mixture was incubated for 1 h at 75 °C and then mixed
with 0.5 (N) NaOH to neutralize the reaction before mixing with 750

l dichloromethane and H2O (1:1,

v/v). This mixture was then centrifuged at 1500 x g for 15 min and the lower phase was separated.
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Standards were dissolved in dichloromethane and analyzed by GC-MS (Trace GC/Polaris Q, Thermo
Fisher Scientific). The injector was set at 200 °C, and the following gradient was used: 70 °C for 5 min,
followed by 4 °C/min up to 140 °C, 2 °C/min up to 185 °C, and 185 °C for 10 min. Helium was used as
the carrier gas, with a flow rate of 1 ml/min, then the molecules were ionized by electron impact at 70
eV and 200 °C. The spectra were collected at the 30−400 m/z range and fatty acid (FA) species were
identified by comparison with the FAME 37 methylated FA mix standard (Supelco, Sigma Aldrich).
3.1.4

Membrane fluidity assay
Approximately 107 trophozoites (control and gGlcT1-overexpressing) were grown and harvested

as described above, and the cells were analyzed using the Membrane Fluidity Kit (M 0271, Marker Gene
Technologies, Inc., Eugene, OR). Cold-shock trophozoites (4 °C, 30 min) were used as positive control.
The cells were resuspended in 200 µl perfusion buffer with 20 µM of fluorescent lipid reagent
(pyrenedecanoic acid) and 0.08% of pluronic F127, provided with the kit. The suspension was shaken on
a rocker for 1 h at RT, and then the cells were washed with PBS and subsequently analyzed using the
ISS K2 Multifrequency Phase and Modulation Fluorometer (ISS, Inc., Champaign, IL). The samples
were excited at 341 nm, and the emission spectra were recorded at 360–500 nm. Crossed polarizers on
excitation and emission beams were used to reduce the background because of scatter. The emission
spectra were then appended with normalized intensities using VINCI software (ISS).
3.1.5

Transmission Electron Microscopy
Cells were grown and encysted as described above. Attached parasites were placed in 2%

paraformaldehyde/2.5% gluteraldehyde in PBS and left for 1 hour at room temperature. The cells were
harvested, then washed with PBS then subsequently embedded and pelleted in 2% agarose. The sample
was post-fixed in 3mL of 1% osmium tetroxide for 1 hour at RT. The cells were then washed with dH2O
before en bloc staining with 1% uranyl acetate for 1 hour at RT.
The cells were then incubated in 1% uranyl acetate for 1 hour at room temperature. Afterwards,
samples were washed with dH20 dehydrated in an ethanol series of 30%, 50%, 70%, 90%, and 100% at
RT. Treatment with Propolyne Oxide (PO) was undertaken before cells were infiltrated with a Eponate
12 resin (EPON). Ninety nanometer (90 nm) sections of the sample was cut using a Leica Ultracut
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UCT7 ultramicrotome before staining with 2% uranyl acetate and lead citrate. Sections were views
under a JEOL 1200 EX transmission electron microscope equipped with an AMT 8 megapixel digital
camera.
3.1.6

Statistical analysis
All values were given as mean values ± S.D., and statistical analyses were generated using SAS

software

ver.

9.2

(SAS

Institute,

Cary,

NC)

and

Graphpad

QuickCalcs

(http://www.graphpad.com/quickcalcs/). Student’s t-test was performed on fatty acid and sterol data.
Statistical values less than 0.01 were considered highly significant, whereas values less than 0.05 were
considered significant. The variances of MS data for GSLs were calculated by one-way ANOVA.
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Table 1: Giardial Lipid genes analyzed by Real Time qRT-PCR

Giardial Lipid Genes

Accession No.

Primers

PI Synthase/CDP-DAG-inositol 3-phosphatidyltransferase (gPIS)

XP_001707169

For: TGGCAGTTTTCTGCTTTGTG Rev: AATCCGATCGCATACTTTGG

PGP synthase/CDP-DAG-glycerol-3-phosphate-3-phosphatidyltransferase

XP_001707005

For: ATGTGGGTTCCTTCAGTTGC Rev: GAGACACGCTGTGATGGAGA

(gPGPS)
PS decarboxylase (gPSD)

XP_001707910

For: CTCCACTGGGCCGTATTTTA Rev: ATGAGCCTGACAGGATGACC

PS synthase (gPSS)

XP_001707737

For: CAGCCTTTGCCTTGCTTATC Rev: GCTAAGGTTGTGTGGCCATT

Phospholipid-transporting ATPase IA, putative (gPLTATPase 1A)

XP_001704967

For: ATGCACAATCGCATCCAGTA Rev: CAGTATCAGCGCCTTTGACA

Lysophosphatidic acid acyltransferase, putative (gLPAAT)

XP_001707002

For: GTCTCCCATCGCCGTAGATA Rev: CGAGTCCAAAACCAGAGAGC

Fatty acid elongase 1 (gFAELO)

XP_001708101

For: TGGCTTCAAATGCAACTCTG

Ceramide glucosyltransferase (gGlcT1)

XP_001704299

For: GCCAACCAGCTCATAATGGT Rev: ATTGACCTTCCCTGCTGATG

Rev: TCGCGTTCTAGACGATCCTT

Acid sphingomyelinase-like phosphodiesterase 3b (gASMase)

XP_001709364

For: AGAGATGACCCAGCGAGCTA Rev: TACCCCCGTCTTTGAAACTG

Serine palmitoyltransferase-1 (gSPT1)

XP_001707207

For: TGATAGACTGCGCAACAACC Rev: CAGCTGCACTGGGATACAGA

Serine palmitoyltransferase-2 (gSPT2)

XP_001704960

For: GTGGGTTGAAGGAGATTGGA Rev: CCGTGTGTCCTGATGAAATG

Phosphoinositide-3-kinase, class 3 (gPI3K)

XP_001708644

For: TACTTCAACGCCATGCTCTG
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Rev: AAAGGCGTAGGGTGATTGTG

3.2 RESULTS
3.2.1

Lipid homeostasis is disrupted upon gGlcT1 overexpression in trophozoites
Because gGlcT1 overexpression induces the synthesis of enlarged vesicles and produces cysts

with reduced viability (Figs. 4, 6, 10), we investigated whether gGlcT1 expression is associated with
increased lipid uptake by Giardia trophozoites, I asked intracellular levels of cholesterol and fatty acid
are altered by gGlcT1, which in turn would affect the membrane fluidity and lipid uptake.
gGlcT1 overexpression elevates the intracellular levels of cholesterol and fatty acid in
trophozoites. Like other lipid molecules, Giardia also has a limited ability to synthesize cholesterol and
fatty acids de novo, which are obtained from the growth medium. Interestingly, both cholesterol and
fatty acids have been shown to be involved in regulating encystation and cyst formation by this
waterborne pathogen (Lujan et al. 1996; Lujan et al. 1996; Yichoy et al. 2009). As gGlcT1
overexpression increased the internalization of NBD-ceramide from the medium (Fig. 4), we thought it
would be important to examine whether gGlcT1 expression also changes the cellular fatty acid and
cholesterol levels. Cholesterol and free fatty acids in control and gGlcT1-overexpressing cells were
analyzed by GC-MS. The sterol analysis showed that cholesterol is the major sterol in both control and
gGlcT1-overexpressing cells (Fig. 11A) and no other sterols, including cholesterylesters or ergosterol,
were detected (Ellis et al. 1996). It is interesting that gGlcT1 overexpression increased the intracellular
level of cholesterol by ~2 fold. Fatty acid analysis (Fig. 11B) revealed that palmitic acid, stearic acid,
oleic acid, and linoleic acid were the major fatty acids present in Giardia trophozoites and that gGlcT1
overexpression increased the level of these fatty acids by ~20, ~22, ~25, and ~38%, respectively. Thus,
as with other lipids as shown in Fig. 7, gGlcT1 expression also increased the uptake of cholesterol and
fatty acids by Giardia (Figs 11A and 11B)
Because the changing of membrane fluidity may increase lipid uptake by trophozoites, we
investigated the possibility that the membrane fluidity could be modified due to the upregulation of
cholesterol and fatty acids by gGlcT1, allowing the cells to internalize excess NBD-ceramide as shown
in Fig. 4. The membrane fluidity was measured using a fluorescent lipid probe, pyrenedecanoic acid, as
detailed in the experimental procedure. This pyrene probe usually forms aggregates called excimers by
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interacting with membrane components that causes a shift of emission spectrum to a longer wavelength.
Therefore, the ratio of monomer to excimer shift could be utilized to measure the change of membrane
fluidity (described by the manufacturer, Marker Gene Technologies). Fig. 11C shows that gGlcT1
overexpression did not produce pyrene excimers from monomers. On the other hand, the trophozoites
treated at 4 oC (cold-shock) showed significant changes from monomer to excimer of the pyrene probe
(Fig. 11D). This suggests that the fluidity of trophozoite plasma membranes is not affected by gGlcT1
overexpression although it increased the uptake of lipid, cholesterol, and fatty acids. We speculate that
the increased lipid uptake by gGlcT1-overexpressed trophozoites occur via receptor- or raft-mediated
lipid endocytosis (Lujan et al. 1996; Hernandez et al. 2007) rather than to the change of membrane
fluidity.

3.2.2

gGlcT1 overexpression is associated with the alterations of lipid metabolic genes in Giardia

Lipid homeostasis plays a critical role in maintaining metabolic balance in eukaryotic cells
(Hermansson et al. 2011). Recent results demonstrate that SLs play important role in maintaining the
overall lipid homeostasis in mammalian cells and any changes of this balance may lead to various
metabolic disorders (Bektas et al. 2010; Pewzner-Jung et al. 2010). A recent study in Giardia also
indicates that the inhibition of GlcCer synthesis by PPMP increases palmitate incorporation and elevates
the levels of diacylglycerol and other neutral lipids (Stefanic et al. 2010), implying a possible cross-talk
between SL and other lipid metabolic pathways. We found that that gGlcT1 overexpression not only
alters the intracellular labeling of lipids (Fig. 4) but also produces enlarged, aggregated ESVs. Based on
these results, it can be hypothesized that gGlcT1-regulated lipid homeostasis is critical for ESV
formation.

Therefore, to gain an overall understanding of lipid gene expression in gGlcT1

overexpressed Giardia, we carried out qRT-PCR analyses. Briefly, control (transfected with empty
plasmid) and gGlcT1 overexpressed trophozoites were subjected to encystation and eleven genes
representing SLs and PLs metabolism (Table-1) were analyzed. Results (Fig.12) show that except
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Figure 11: gGlcT1 overexpression increases cholesterol and fatty acid levels but does not alter
membrane fluidity
Control and gGlcT1-overexpressing Giardia were subjected to Folch’s partition and subsequent
fractionation to separate sterols and fatty acids. A) Sterols were extracted in a solvent containing
chloroform, methanol, and water followed by GC-MS analysis. Stigmasterol was added as an external
standard to quantify cholesterol. When compared to control, the amount of cholesterol present in
+GlcT1 is ~2-fold higher. The experiment was carried out in triplicate, and data are shown as relative
quantity ±S.D. of two separate experiments (**, p<0.01). B) Fatty acids extracted from Giardia were
subjected to methylation and analyzed by GC-MS. Similar to cholesterol results, the amount of fatty
acids also increased in +GlcT1 trophozoites. The experiment was carried out in triplicate, and data are
shown as relative quantity ±S.D. of two separate experiments (***, p<0.001). C) membrane fluidity was
assessed using a fluorescent lipid, pyrenedecanoic acid. The monomer/excimer ratio was calculated by
normalizing fluorescence intensities. Control (black line, transfected with empty plasmid) and gGlcT150

overexpressed (gGlcT1) cells (red and green lines, two separate gGlcT1-overexpressing trophozoite
samples) are shown and there no change in membrane fluidity between the cell types. D) changes of
membrane fluidity in cold-shock trophozoites. The black line indicates control trophozoites incubated at
25 °C for 30 min, and the red line denotes cold-shock trophozoites kept at 4 °C also for 30 min before
conducting the. In both cases (C and D) experiments were repeated several times with different cell
preparations, and the results shown here came from a single experiment.
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Figure 12: Real Time qRT-PCR Analysis of Lipid Genes in gGlcT1 Overexpressed Giardia
Real Time qRT-PCR analyses of giardial cells from trophozoites 12h, 24h encysting cells and
complete cysts. RNA was extracted with Trizol reagent and cDNA was synthesized by RT-PCR. cDNA
was analyzed using SYBR Green with the BioRad MyIQ system. Using various lipid genes shows that
GlcT1 overexpression did not affect many lipid genes. The main lipid genes that were affected were the
SPT genes where expression increased at 12h, but decreased at the cyst stage. In the other lipid genes
group gFAELO in gGlcT1 overexpressed cells showed an increase in 12h as well, but a decrease in both
24h and cyst stages.
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Figure 13: Real Time qRT-PCR Analysis of Lipid Genes in gGlcT1 Overexpressed Giardia
gPIS, the phospholipid gene showed over a 3-fold increase at the cyst stage during gGlcT1
overexpression. All other lipid profiles show only a decrease in the cyst stage meanwhile PGPS shows a
slight increase in cyst stage, but a slight decrease in 12h encysting due to gGlcT1 overexpression.
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gglct1, the expression of all lipid genes, investigated here are maximum in cysts.

In gGlcT1-

overexpressed cells, however, the transcripts of two serine-palmitoyltransferase genes (gspt-1 and gspt2) are increased ~10 fold and ~30 fold in 12h and 24h encysting cells, respectively, followed by a sharp
decline in cysts. The giardial fatty acid elongase gene (gfaelo) showed a ~11-fold increase in expression
at 12h encysting (Fig 12). Interestingly, the expression of acid sphingomyelinase gene (gasmase)
remains unaltered throughout the encystation cycle in gGlcT1-overexpressed cells (Fig 13). As expected
the synthesis of gglct1 mRNA is increased ~9 and ~1.5 fold, respectively in 12 and 24h overexpressed
encysting Giardia. On the contrary, the transcripts of other PL genes [e.g., phosphatidylinositol synthase
(gPIS), phosphatidylglycerol synthase (gPGPS), phosphatidylserine synthase (gPSS), phospholipid
transferase (gPLT), phosphatidylserine decarboxylase (gPSD), phospholipid transporting ATPase
(gPLTA) and phosphatidylinositol-3-kinase (gPI3K) are down-regulated in cysts by gGlcT1 (Fig. 13).

3.2.3 gGlcT1 overexpression induces production of multi-layer ESVs

As previously shown, overexpression caused the synthesis of enlarged, aggregated ESVs under
confocal microscopy using anti-cyst antibody. I decided to investigate using Transmission Electron
Microscopy (TEM) to observe any structural differences of ESVs between wild-type and gGlcT1overexpressed Giardia (Fig 14). Control ESVs show a uniform, thin-membrane layer surrounding the
dense cyst wall material being transported to lay down the cyst wall. However, parasites that have
gGlcT1 overexpressed, exhibit a vesicle that has enlarged, multi-layer membranes. In some ESVs,
vacuole-like structures can be seen lining the surface of the ESV membrane whereas other ESVs has
protrusions where thick membranes are entangled and aggregated around the cyst wall material.
Therefore, along with the increase of fatty acid and cholesterol incorporation and internalization of
fluorescent-labeled lipids, modulation of gGlcT1 changes the structural morphology of ESVs.
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Control ESV

+GlcT1 ESV

Figure 14: Analysis of ESV morphology under Transmission Electron Microscopy
Control and gGlcT1-overexpressed encysting Giardia were subjected to fixation, embedding and
sectioning for electron microscopy. Several images of control show a thin bilayer surrounding the ESVs
that transport cyst wall material to the plasma membrane. The ESVs themselves are overall round and
uniform when compared to the +GlcT1 encysting cells which may show irregularities with the
membrane. +GlcT1 encysting cells have multi-layer membranes that may contain vacuoles. The
membranes of +GlcT1 ESVs also have tangled and enlarged membranes surrounding the cyst wall
material. Bar: 0.5µm.
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3.3 CONCLUSION
Because gGlcT1 overexpression induces the synthesis of enlarged ESVs during encystation, I
thought that this could be due to the increased influx and utilization of exogenous lipids by the parasite.
It was observed that gGlcT1 overexpression indeed elevated the levels of membrane lipids, cholesterol,
and fatty acids. I presumed that this increased uptake of lipid molecules could be due to the changes of
membrane fluidity/permeability caused by elevated gGlcT1 expression. However, when the membrane
fluidity was tested, no significant effect was observed. In addition, qRT-PCR analysis indicated that the
transcripts of only 3 genes (gspt1, gspt2, and gfaelo) are differentially expressed in gGlcT1
overexpressed trophozoites, which suggests that the effect of gGlcT1 overexpression is specific and
selective and that this important enzyme of SL pathway plays a regulatory role during encystation at
both the genetic and epigenetic levels. I speculate that the overexpression of gGlcT1 activates receptormediated endocytosis and transport proteins to internalize lipids and fatty acids by Giardia. However,
more in-depth experiments should be carried out to test this possibility.
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Chapter 4: Discussion
Giardia, an intestinal parasite, is known to cause gastrointestinal discomfort that could lead to
symptoms like vomiting, diarrhea, indigestion, and abdominal cramps. Metronidazole, an analogue of
nitroimidazole, was marketed in 1962 and used as an anti-giardial agent. Later on, albendazole and the
furazolidone group of compounds were also introduced to treat the infection (Gardner et al. 2001).
Unfortunately, many of these drugs are not specific for Giardia and may produce adverse side effects.
Therefore, it is imperative to discover new targets that could be exploited to develop novel anti-giardial
agents. In my dissertation, I have demonstrated that gGlcT1 regulates ESV biogenesis and cyst viability
and that it may serve as a good candidate for drug targeting and vaccine development in the future.
In this dissertation, an attempt was made to elucidate the mechanism of action of gGlcT1 and
how it regulates encystation and cyst production by Giardia. Analysis of the Giardia Genome Database
(www.Giardiadb.org) revealed that only five SL metabolic genes (including gglct1) are present in this
parasite and that all of these genes are differentially regulated during encystation (Hernandez et al.
2008). Interestingly, we and others have observed that PPMP, an inhibitor for GlcCer synthesis, blocks
encystation and cyst production by Giardia (Hernandez et al. 2008; Sonda et al. 2008; Stefanic et al.
2010). Because earlier studies (Hernandez et al. 2008) from our laboratory indicated that gGlcT1 is the
only SL biosynthesis enzyme that regulates the process of encystation in Giardia, I decided to study the
mechanism by which gGlcT1 regulates the process of encystation. To initiate this, I standardized the
assay of gGlcT1 following the protocols that were described for other organisms, with some essential
modifications (Uchida et al. 2002; Couto et al. 2004). I found that the gGlcT1 activity increases during
encystation and attains its highest activity level in cysts. To confirm the specificity of this enzyme,
PPMP was added in the reaction mixture before determining the activity. It is of interest that PPMP,
which inhibited the gGlcT1 activity in trophozoites and early encysting cells, had no effect on cyst
enzyme (gGlcT1), suggesting that Giardia synthesizes PPMP-sensitive and -resistant gGlcT1. To further
investigate this matter, the gglct1 gene was knocked down with anti-gglct1 morpholino oligonucleotide.
Figure 4B and 7A demonstrate that the morpholino oligonucleotide lowered gGlcT1 activity
significantly in non-encysting and encysting trophozoites as well as in cysts. Although it is not clear
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why cyst-stage gGlcT1 is not inhibited by PPMP (Fig. 4B), Stefanic et al. (2010) reported that Giardia
synthesizes di- and tri-hexosylceramides in encysting cells and cysts, indicating that gGlcT1 changes its
substrate preferences during encystation and converts mono-hexosylceramide (i.e., GlcCer) to di- and
tri-hexosylceramides. Hillig et al. (2003) reported that GlcT1 in plant cells shows broader substrate
affinities and functions as a sterol glucoside synthase. Interestingly, GlcT1 in Giardia and plants are
remarkably similar as far as the amino acid identity and sequence motifs are concerned, and therefore,
like plant enzyme, gGlcT1 exhibits broader substrate preferences and catalyzes the synthesis of complex
glycosylceramides, as shown in Fig. 7C. However, additional experiments are required to confirm this
possibility.
gGlcT1 overexpression increased the activity of the enzyme by ~3 fold, induced enlarged/
aggregated ESVs, and produced non-viable cysts. However, when overexpressed trophozoites were
transfected with anti-gglct1 morpholino oligonucleotide, the enzyme activity, ESV morphologies, and
cyst viability returned to normal (Fig 7A, 8 and 10). Electron microscopy results showed that gGlcT1
overexpression also produced multi-layered ESVs, which is sometimes associated with vacuoles. Nontransfected encysting cells showed normal, bilayered membrane ESVs (Fig 14). A report of mink lung
type II alveolar cells (Mv1Lu) transfected with β1–6-N-acetylglucosaminyl transferase V produced
multi-lamellar vacuoles via autophagy. Upon treatment of the alveolar cells with a known inhibitor of
autophagy, 3-methyladenine, the number of multi-lamellar vacuoles decreased (Hariri et al. 2000).
Therefore, a similar kind of autophagic reaction may also occur in gGlcT1 overexpressed Giardia that
induces the synthesis of enlarged and multi-layered ESVs during encystation. My results also showed
that the overexpression of gGlcT1 alters the lipid balance by importing excess lipids, fatty acids, and
cholesterol from the growth medium and that those lipids are most likely to be recruited by the cell to
synthesize morphologically altered ESVs (Fig. 11 and 14). From these results, I postulate that gGlcT1
is part of a highly regulated pathway that plays a critical role in maintaining ESV biogenesis and cyst
production and that it does so by maintaining the cellular lipid homeostasis (discussed in Chapter 3).
Like Giardia, gGlcT1 overexpression also influences several body-fat storage genes in Drosophila
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(Kohyama-Koganeya et al. 2011), which suggests that one of the functions of GlcT1 is to store lipids
and maintain the overall lipid content for energy production and metabolic purposes.
Another important aspect of my thesis is identifying the fact that PPMP does not block giardial
encystation by interfering with cytokinesis as previously reported. It was proposed that inhibiting the
blocking of gGlcT1 activity interferes with cytokinesis and thereby obstructs encystation (Sonda et al.
2008; Stefanic et al. 2010). In the current study, however, it was noted that although the treatment of
trophozoites with anti-gglct1 morpholino oligonucleotide inhibited gGlcT1 activity, it failed to affect the
growth, replication, and cytokinesis of trophozoites (Fig 9). It is interesting that anti-gglct1 morpolino
inhibited the biogenesis of ESVs and cyst production, which suggests that even though gGlcT1 activity
is linked to encystation the blocking of trophozoite replication/cytokinesis by PPMP is an off-target
effect and does not involve gGlcT1. It was shown earlier that PDMP, an analogue of PPMP, regulates
the cell cycle by inhibiting cyclin-dependent kinases (cdk2 and p34cdc2), which further supports my
results of non-specific inhibition by PPMP (Rani et al. 1995; Norris-Cervetto et al. 2004; Dijkhuis et al.
2006).
At this point, it is not yet clear how gGlcT1 regulates the cyst-wall biosynthesis. The rigid and
rugged cyst wall of Giardia contains a fibrous and filamentous structure that is made of several cystwall proteins (CWP1, 2, and 3) and carbohydrates (mostly β-GalNAc homopolymer) (Gerwig et al.
2002; Chatterjee et al. 2010) It was proposed that CWP1 is a lectin that preferentially binds to GalNAc
homopolymer to form a curled, fibril-type arrangement (Chatterjee et al. 2010). As far as GalNAc
polymer is concerned, it forms flexible structures (right- or left-handed) with strong inter-chain
interactions of an insoluble nature. Insoluble GalNAc homopolymer is synthesized from UDP-GalNAc
with the help of an enzyme, called cyst-wall synthase (CWS, N-acetyl-galactosaminyltransferase)
(Jarroll et al. 2001). It is of interest that so far no mechanism has been proposed to explain how the
synthesis of cyst-wall components is initiated in the cytoplasm and transported to plasma membranes,
and how the entire polymer coat is deposited on the outer face of the plasma membranes. In the case of
cell-wall biosynthesis in gram-positive bacteria, it has been demonstrated that a complex saccharide- and
peptide-containing lipid molecule (undecaprenyl disaccharide pentapeptide) acts as a carrier to transport
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preformed peptidoglycan (synthesized in cytoplasm) to the plasma membrane to form cell walls
(Navarre et al. 1999). I have demonstrated that gGlcT1 activity is increased during encystation (Fig. 4A)
and that the relative abundances of mono-, di-, and tri-hexosylceramide are higher in encysting cells
than non-encysting trophozoites (Fig. 7C). Therefore, it is likely that the formation of hexosylceramides
in encysting cells initiates and transports cyst-wall components across the plasma membranes and lays
down the cyst wall. It is also possible that hexosylceramides are present in the cyst wall and that their
interactions with proteins and amino sugars (present in the cyst wall) are important for maintaining the
integrity of cysts. It is also possible that gGlcT1 interacts with CWS to facilitate the encystation process.
However, additional experiments are required to test these possibilities.

4.1 PROPOSED MODEL
Based on my results, I have inferred a comprehensive model describing how gGlcT1 modulates
ESV biogenesis and cyst production (Fig. 15). The model reveals that the activity gGlcT1 enzyme
(located in the ER) is stimulated during encystation and facilitates the synthesis of GlcCer from
ceramide. Because Giardia is unable to synthesize its own lipids, including ceramide, it is taken up by
Giardia from the culture medium via clathrin-dependent endocytosis, targeted toward the ER, and used
as a substrate for gGlcT1 (Hernandez et al. 2007; Hernandez et al. 2008). Apparently, this reaction takes
place in the ER, which is also the site of ESV biogenesis. GlcCer and other complex ceramides
synthesized by the gGlcT1 reaction then participate in ESV biogenesis. My results also suggest that
gGlcT1, through an unknown mechanism, regulates lipid and fatty acid uptake from the environment.
As reviewed before (Yichoy et al. 2011), Giardia synthesizes putative phospholipid transporting
ATPases (flippases), fatty acid transporters, and clathrin-coated vesicles to transport lipid and fatty acids
from the cell exterior. It is possible that these exogenous lipids are used to synthesize membrane-bound
ESVs and that this entire process is under the control of gGlcT1. When the enzyme is overexpressed, it
severely alters the lipid internalization and affects the overall lipid homeostasis. Excess lipids then
interfere with normal ESV synthesis and produce enlarged and multi-layered ESVs that are detrimental
to viable cyst production.
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A. Control Encysting

B. +GlcT1 Encysting

Figure 15: Proposed model of Giardial encystation pathway
Based on the results from this thesis, we have compiled an encystation pathway which shows (A)
control cells and (B) gGlcT1-overexpressed cells.
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4.2 CONCLUSION AND FUTURE DIRECTIONS
During its colonization in the human small intestine, Giardia is exposed to various dietary lipids.
These intestinal lipids facilitate the growth and encystation of this waterborne pathogen. Encystation and
cyst formation are important because they allow the parasite to survive in the environment and infect
new hosts. My results show that the regulated expression of gGlcT1 activity is critical for cyst
formation. In addition, my study indicates that gGlcT1 activity increases during encystation and is
highest in cyst. Consistent with this result, I have also observed that di- and tri-hexosylceramides are
synthesized during encystation, implicating a possible link between cyst-specific gGlcT1 and
hexosylceramide syntheses. The future study will reveal the unique role of gGlcT1 and its product(s) in
cyst formation. If successful, the study will set the stage for future investigations to develop potential
therapies targeting glycospingolipids in Giardia. In recent years, efforts have been underway to produce
vaccine against Giardia trophozoites (Rivero et al. 2010). The results generated from this dissertation
should provide valuable information about whether gGlcT1 knockdown-attenuated cysts with reduced
viability could be utilized as a live vaccine candidate against giardiasis in the future.
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